BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495-500. [PMID: 11172192 DOI: 10.1056/nejm200102153440706] [Cited by in Crossref: 1501] [Cited by in F6Publishing: 539] [Article Influence: 75.1] [Reference Citation Analysis]
Number Citing Articles
1 Hessien MH, El-Sharkawi IM, El-Barbary AA, El-Beltagy DM, Snyder N. Non-invasive index of liver fibrosis induced by alcohol, thioacetamide and Schistosomal infection in mice. BMC Gastroenterol 2010;10:53. [PMID: 20515488 DOI: 10.1186/1471-230X-10-53] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
2 Wang M, Liu R, Liang Y, Yang G, Huang Y, Yu C, Sun K, Lai Y, Xia Y. Iron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patients. United European Gastroenterol J 2017;5:94-103. [PMID: 28405327 DOI: 10.1177/2050640616646525] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
3 Umemura T, Joshita S, Sekiguchi T, Usami Y, Shibata S, Kimura T, Komatsu M, Matsumoto A, Ota M, Tanaka E. Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis. Am J Gastroenterol. 2015;110:857-864. [PMID: 25916223 DOI: 10.1038/ajg.2015.118] [Cited by in Crossref: 95] [Cited by in F6Publishing: 86] [Article Influence: 15.8] [Reference Citation Analysis]
4 Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology. 2011;259:749-756. [PMID: 21460032 DOI: 10.1148/radiol.11101942] [Cited by in Crossref: 285] [Cited by in F6Publishing: 260] [Article Influence: 28.5] [Reference Citation Analysis]
5 Beckmann MG, Bahr MJ, Hadem J, Bredt M, Wedemeyer H, Schneider AS, Kubicka S, Manns MP, Strassburg CP, Wedemeyer J. Clinical relevance of transjugular liver biopsy in comparison with percutaneous and laparoscopic liver biopsy. Gastroenterol Res Pract 2009;2009:947014. [PMID: 19920868 DOI: 10.1155/2009/947014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
6 Fung J, Lai CL, Seto WK, Yuen MF. The use of transient elastography in the management of chronic hepatitis B. Hepatol Int. 2011;5:868-875. [PMID: 21695588 DOI: 10.1007/s12072-011-9288-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
7 Vanderschaeghe D, Laroy W, Sablon E, Halfon P, Van Hecke A, Delanghe J, Callewaert N. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteomics. 2009;8:986-994. [PMID: 19181623 DOI: 10.1074/mcp.M800470-MCP20042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Venuto CS, Markatou M, Woolwine-Cunningham Y, Furlage R, Ocque AJ, DiFrancesco R, Dumas EO, Wallace PK, Morse GD, Talal AH. Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques. Antimicrob Agents Chemother 2017;61:e02283-16. [PMID: 28264852 DOI: 10.1128/AAC.02283-16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Sira MM, Behairy BE, Abd-Elaziz AM, Abd Elnaby SA, Eltahan EE. Serum Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) in Children with Chronic Hepatitis C: Relation to Liver Fibrosis and Viremia. Hepat Res Treat. 2014;2014:307942. [PMID: 25295185 DOI: 10.1155/2014/307942] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
10 Moon KM, Kim G, Baik SK, Choi E, Kim MY, Kim HA, Cho MY, Shin SY, Kim JM, Park HJ, Kwon SO, Eom YW. Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis. Clin Mol Hepatol 2013;19:389-98. [PMID: 24459644 DOI: 10.3350/cmh.2013.19.4.389] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
11 Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851. [PMID: 18328931 DOI: 10.1016/s0140-6736(08)60383-9] [Cited by in Crossref: 1212] [Cited by in F6Publishing: 536] [Article Influence: 93.2] [Reference Citation Analysis]
12 Kennedy P, Wagner M, Castéra L, Hong CW, Johnson CL, Sirlin CB, Taouli B. Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions. Radiology 2018;286:738-63. [PMID: 29461949 DOI: 10.1148/radiol.2018170601] [Cited by in Crossref: 119] [Cited by in F6Publishing: 106] [Article Influence: 39.7] [Reference Citation Analysis]
13 Iacob DG, Rosca A, Ruta SM. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World J Gastroenterol 2020; 26(11): 1113-1127 [PMID: 32231417 DOI: 10.3748/wjg.v26.i11.1113] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
14 Armstrong MJ, Corbett C, Hodson J, Marwah N, Parker R, Houlihan DD, Rowe IA, Hazlehurst JM, Brown R, Hübscher SG. Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice. Postgrad Med J. 2013;89:685-692. [PMID: 23924687 DOI: 10.1136/postgradmedj-2012-131640] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
15 Hassan K, Bhalla V, Regal MEE, A-Kader HH. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic. World J Gastroenterol 2014; 20(34): 12082-12101 [PMID: 25232245 DOI: 10.3748/wjg.v20.i34.12082] [Cited by in CrossRef: 110] [Cited by in F6Publishing: 94] [Article Influence: 15.7] [Reference Citation Analysis]
16 Bialecki ES, Di Bisceglie AM. Diagnosis of hepatocellular carcinoma. HPB (Oxford). 2005;7:26-34. [PMID: 18333158 DOI: 10.1080/13651820410024049] [Cited by in Crossref: 132] [Cited by in F6Publishing: 125] [Article Influence: 12.0] [Reference Citation Analysis]
17 Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851. [PMID: 18328931 DOI: 10.1056/s0140-6736(08)60383-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Xu XY, Wang WS, Zhang QM, Li JL, Sun JB, Qin TT, Liu HB. Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis. World J Clin Cases 2019; 7(15): 2022-2037 [PMID: 31423434 DOI: 10.12998/wjcc.v7.i15.2022] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
19 Amorim VB, Parente DB, Paiva FF, Oliveira Neto JA, Miranda AA, Moreira CC, Fernandes FF, Campos CFF, Leite NC, Perez RM, Rodrigues RS. Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? World J Hepatol 2020; 12(9): 661-671 [PMID: 33033571 DOI: 10.4254/wjh.v12.i9.661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ciccarelli N, Fabbiani M, Brita AC, De Marco R, Grima P, Gagliardini R, Borghetti A, Cauda R, Di Giambenedetto S. Liver fibrosis is associated with cognitive impairment in people living with HIV. Infection 2019;47:589-93. [PMID: 30784024 DOI: 10.1007/s15010-019-01284-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Lee JG, Sohn JH, Jeong JY, Kim TY, Kim SM, Cho YS, Kim Y. Combined effect of hepatic venous pressure gradient and liver stiffness on long-term mortality in patients with cirrhosis. Korean J Intern Med 2020;35:88-98. [PMID: 30791681 DOI: 10.3904/kjim.2018.151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Lu Y, Wei J, Tang Y, Yuan Y, Huang Y, Zhang Y, Li Y. Evaluation of fatty liver fibrosis in rabbits using real-time shear wave elastography. Exp Ther Med. 2014;8:355-362. [PMID: 25009583 DOI: 10.3892/etm.2014.1749] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
23 Taouli B, Ehman RL, Reeder SB. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol. 2009;193:14-27. [PMID: 19542391 DOI: 10.2214/ajr.09.2601] [Cited by in Crossref: 128] [Cited by in F6Publishing: 46] [Article Influence: 10.7] [Reference Citation Analysis]
24 Razlan H, Marzuki NM, Tai ML, Shamsul AS, Ong TZ, Mahadeva S. Diagnostic value of the C methacetin breath test in various stages of chronic liver disease. Gastroenterol Res Pract. 2011;2011:235796. [PMID: 21687605 DOI: 10.1155/2011/235796] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
25 Schaible J, Utpatel K, Verloh N, Einspieler I, Pregler B, Zeman F, Wiggermann P, Schreyer AG, Stroszczynski C, Beyer LP. Full-Core Biopsy Systems Take Larger Liver Tissue Samples with Lower Fragmentation Rates Than Conventional Side-Notch Systems: A Randomized Trial. Cancer Manag Res 2020;12:1121-8. [PMID: 32104092 DOI: 10.2147/CMAR.S209824] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Colombo M. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007;56:968-73. [PMID: 17255218 DOI: 10.1136/gut.2006.111302] [Cited by in Crossref: 572] [Cited by in F6Publishing: 529] [Article Influence: 40.9] [Reference Citation Analysis]
27 Yin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, Fidler JL, Ehman RL. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007;5:1207-1213.e2. [PMID: 17916548 DOI: 10.1016/j.cgh.2007.06.012] [Cited by in Crossref: 640] [Cited by in F6Publishing: 566] [Article Influence: 45.7] [Reference Citation Analysis]
28 Schenk JP, Selmi B, Flechtenmacher C, Sakka SE, Teufel U, Engelmann G. Real-time tissue elastography (RTE) for noninvasive evaluation of fibrosis in liver diseases in children in comparison to liver biopsy. J Med Ultrason (2001). 2014;41:455-462. [PMID: 27278026 DOI: 10.1007/s10396-014-0542-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
29 Wong GL. Update of liver fibrosis and steatosis with transient elastography (Fibroscan). Gastroenterol Rep (Oxf) 2013;1:19-26. [PMID: 24759663 DOI: 10.1093/gastro/got007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
30 Ding R, Zheng J, Huang D, Wang Y, Li X, Zhou X, Yan L, Lu W, Yang Z, Zhang Z. INR-to-platelet ratio (INPR) as a novel noninvasive index for predicting liver fibrosis in chronic hepatitis B. Int J Med Sci 2021;18:1159-66. [PMID: 33526976 DOI: 10.7150/ijms.51799] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 张碧莹, 李晓光, 胥婕. 实时组织弹性成像评价肝纤维化分级的Meta分析. 世界华人消化杂志 2014; 22(19): 2774-2779 [DOI: 10.11569/wcjd.v22.i19.2774] [Reference Citation Analysis]
32 Nassef YE, Shady MM, Galal EM, Hamed MA. Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children. Mem Inst Oswaldo Cruz 2013;108:887-93. [PMID: 24141960 DOI: 10.1590/0074-0276130139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
33 Qayyum A, Chen DM, Breiman RS, Westphalen AC, Yeh BM, Jones KD, Lu Y, Coakley FV, Callen PW. Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? Clin Imaging. 2009;33:110-115. [PMID: 19237053 DOI: 10.1016/j.clinimag.2008.06.036] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
34 Cashmore MT, McCann AJ, Wastling SJ, McGrath C, Thornton J, Hall MG. Clinical quantitative MRI and the need for metrology. Br J Radiol 2021;94:20201215. [PMID: 33710907 DOI: 10.1259/bjr.20201215] [Reference Citation Analysis]
35 Verloh N, Utpatel K, Haimerl M, Zeman F, Fellner C, Fichtner-Feigl S, Teufel A, Stroszczynski C, Evert M, Wiggermann P. Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation. Sci Rep 2015;5:15408. [PMID: 26478097 DOI: 10.1038/srep15408] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
36 Zhao F, Wang YX, Yuan J, Deng M, Wong HL, Chu ES, Go MY, Teng GJ, Ahuja AT, Yu J. MR T1ρ as an imaging biomarker for monitoring liver injury progression and regression: an experimental study in rats with carbon tetrachloride intoxication. Eur Radiol 2012;22:1709-16. [PMID: 22752522 DOI: 10.1007/s00330-012-2419-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
37 Wong GLH. Transient elastography: Kill two birds with one stone? World J Hepatol 2013; 5(5): 264-274 [PMID: 23717737 DOI: 10.4254/wjh.v5.i5.264] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 7.4] [Reference Citation Analysis]
38 Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D, Capron D, Abella A, Massard J, Ngo Y, Munteanu M, Mercadier A, Manns M, Albrecht J. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol. 2005;4:10. [PMID: 16375767 DOI: 10.1186/1476-5926-4-10] [Cited by in Crossref: 201] [Cited by in F6Publishing: 195] [Article Influence: 12.6] [Reference Citation Analysis]
39 Yarnykh VL, Tartaglione EV, Ioannou GN. Fast macromolecular proton fraction mapping of the human liver in vivo for quantitative assessment of hepatic fibrosis. NMR Biomed 2015;28:1716-25. [PMID: 26503401 DOI: 10.1002/nbm.3437] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
40 Menten R, Leonard A, Clapuyt P, Vincke P, Nicolae AC, Lebecque P. Transient elastography in patients with cystic fibrosis. Pediatr Radiol 2010;40:1231-5. [PMID: 20135110 DOI: 10.1007/s00247-009-1531-z] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 6.1] [Reference Citation Analysis]
41 Fintelmann FJ, Troschel FM, Kuklinski MW, McDermott S, Petranovic M, Digumarthy SR, Sharma A, Troschel AS, Price MC, Hariri LP, Gilman MD, Shepard JO, Sequist LV, Piotrowska Z. Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor-Mutant Lung Cancer. Oncologist 2019;24:1570-6. [PMID: 31152082 DOI: 10.1634/theoncologist.2019-0158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
42 Tachi Y, Hirai T, Toyoda H, Tada T, Hayashi K, Honda T, Ishigami M, Goto H, Kumada T. Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus. PLoS One 2015;10:e0133515. [PMID: 26214180 DOI: 10.1371/journal.pone.0133515] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
43 Zhao H, Song P, Meixner DD, Kinnick RR, Callstrom MR, Sanchez W, Urban MW, Manduca A, Greenleaf JF, Chen S. External vibration multi-directional ultrasound shearwave elastography (EVMUSE): application in liver fibrosis staging. IEEE Trans Med Imaging 2014;33:2140-8. [PMID: 25020066 DOI: 10.1109/TMI.2014.2332542] [Cited by in Crossref: 35] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
44 Seo YS, Kim MN, Kim SU, Kim SG, Um SH, Han KH, Kim YS. Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy. Medicine (Baltimore). 2016;95:e2985. [PMID: 27015173 DOI: 10.1097/md.0000000000002985] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
45 Wietzke-Braun P, Braun F, Schott P, Ramadori G. Is laparoscopy an advantage in the diagnosis of cirrhosis in chronic hepatitis C virus infection? World J Gastroenterol 2003; 9(4): 745-750 [PMID: 12679924 DOI: 10.3748/wjg.v9.i4.745] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
46 Zhang GL, Xu SC, Zeng J, Chen Z, Li YP, Zhang T, Gao ZL. Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease. Dis Markers 2019;2019:2585409. [PMID: 31885733 DOI: 10.1155/2019/2585409] [Reference Citation Analysis]
47 Leitão J, Carvalhana S, Silva AP, Velasco F, Medeiros I, Alves AC, Bourbon M, Oliveiros B, Carvalho A, Cortez-Pinto H. No Evidence for Lower Levels of Serum Vitamin D in the Presence of Hepatic Steatosis. A Study on the Portuguese General Population. Int J Med Sci 2018;15:1778-86. [PMID: 30588203 DOI: 10.7150/ijms.26586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
48 Gallego-Durán R, Cerro-Salido P, Gomez-Gonzalez E, Pareja MJ, Ampuero J, Rico MC, Aznar R, Vilar-Gomez E, Bugianesi E, Crespo J, González-Sánchez FJ, Aparcero R, Moreno I, Soto S, Arias-Loste MT, Abad J, Ranchal I, Andrade RJ, Calleja JL, Pastrana M, Iacono OL, Romero-Gómez M. Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease. Sci Rep 2016;6:31421. [PMID: 27514671 DOI: 10.1038/srep31421] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
49 Kim JW, Lee YS, Park YS, Kim BH, Lee SY, Yeon JE, Lee CH. Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease. Sci Rep 2020;10:2671. [PMID: 32060386 DOI: 10.1038/s41598-020-59601-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
50 Cristina SJL, Marta CM, Mercedes GS, Almudena PM, Álvaro HM, Luis VSJ, Tesifón PC. Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases. Clin Mol Hepatol 2018;24:384-91. [PMID: 29969885 DOI: 10.3350/cmh.2018.0004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
51 Dvorak K, Stritesky J, Petrtyl J, Vitek L, Sroubkova R, Lenicek M, Smid V, Haluzik M, Bruha R. Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice--an exploratory case-control study. PLoS One 2014;9:e111551. [PMID: 25350286 DOI: 10.1371/journal.pone.0111551] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
52 Kalantari H, Hoseini H, Babak A, Yaran M. Validation of hepascore as a predictor of liver fibrosis in patients with chronic hepatitis C infection. Hepat Res Treat. 2011;2011:972759. [PMID: 22254137 DOI: 10.1155/2011/972759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
53 Song JE, Lee DW, Kim EY. Endoscopic Ultrasound Real-Time Elastography in Liver Disease. Clin Endosc 2018;51:118-9. [PMID: 29618176 DOI: 10.5946/ce.2018.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, Hassanein T, Asbach P, Godfrey EM, Yin M, Chen J, Keaveny AP, Bridges M, Bohte A, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 2015; 13: 440-451. e6. [PMID: 25305349 DOI: 10.1016/j.cgh.2014.09.046] [Cited by in Crossref: 288] [Cited by in F6Publishing: 253] [Article Influence: 41.1] [Reference Citation Analysis]
55 Castera L. Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int. 2011;5:625-634. [PMID: 21484142 DOI: 10.1007/s12072-010-9240-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
56 Friedrich-rust M, Hadji-hosseini H, Kriener S, Herrmann E, Sircar I, Kau A, Zeuzem S, Bojunga J. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur Radiol 2010;20:2390-6. [DOI: 10.1007/s00330-010-1820-9] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
57 Vanderschaeghe D, Laroy W, Sablon E, Halfon P, Van Hecke A, Delanghe J, Callewaert N. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteomics. 2009;8:986-994. [PMID: 19181623 DOI: 10.1074/mcp.m800470-mcp200] [Cited by in Crossref: 89] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
58 Park HS, Choe WH, Han HS, Yu MH, Kim YJ, Jung SI, Kim JH, Kwon SY. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study. World J Gastroenterol 2019; 25(25): 3256-3267 [PMID: 31333316 DOI: 10.3748/wjg.v25.i25.3256] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
59 Song P, Mellema DC, Sheedy SP, Meixner DD, Karshen RM, Urban MW, Manduca A, Sanchez W, Callstrom MR, Greenleaf JF, Chen S. Performance of 2-Dimensional Ultrasound Shear Wave Elastography in Liver Fibrosis Detection Using Magnetic Resonance Elastography as the Reference Standard: A Pilot Study. J Ultrasound Med 2016;35:401-12. [PMID: 26782164 DOI: 10.7863/ultra.15.03036] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
60 Kose S, Ersan G, Tatar B, Adar P, Sengel BE. Evaluation of Percutaneous Liver Biopsy Complications in Patients with Chronic Viral Hepatitis. Eurasian J Med. 2015;47:161-164. [PMID: 26644763 DOI: 10.5152/eurasianjmed.2015.107] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
61 Friedman LS. Controversies in liver biopsy: who, where, when, how, why? Curr Gastroenterol Rep 2004;6:30-6. [PMID: 14720451 DOI: 10.1007/s11894-004-0023-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
62 Göbel T, Schadewaldt-Tümmers J, Greiner L, Poremba C, Häussinger D, Erhardt A. Transient elastography improves detection of liver cirrhosis compared to routine screening tests. World J Gastroenterol 2015; 21(3): 953-960 [PMID: 25624730 DOI: 10.3748/wjg.v21.i3.953] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
63 Shao LN, Zhang ST, Zhou SH, Yu WJ, Liu M. Atypical Chemokine Receptor 1 polymorphism cannot be used as an indicator of liver fibrosis progression in Hepatitis C virus positive patients. Pak J Med Sci 2017;33:1134-7. [PMID: 29142552 DOI: 10.12669/pjms.335.12590] [Reference Citation Analysis]
64 Hernando D, Levin YS, Sirlin CB, Reeder SB. Quantification of liver iron with MRI: state of the art and remaining challenges. J Magn Reson Imaging. 2014;40:1003-1021. [PMID: 24585403 DOI: 10.1002/jmri.24584] [Cited by in Crossref: 135] [Cited by in F6Publishing: 122] [Article Influence: 19.3] [Reference Citation Analysis]
65 Huang R, Jiang N, Yang R, Geng X, Lin J, Xu G, Liu D, Chen J, Zhou G, Wang S, Luo T, Wu J, Liu X, Xu K, Yang X. Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B. Exp Ther Med. 2016;11:1673-1677. [PMID: 27168788 DOI: 10.3892/etm.2016.3135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
66 Patel J, Bettencourt R, Cui J, Salotti J, Hooker J, Bhatt A, Hernandez C, Nguyen P, Aryafar H, Valasek M, Haufe W, Hooker C, Richards L, Sirlin CB, Loomba R. Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis. Therap Adv Gastroenterol 2016;9:692-701. [PMID: 27582882 DOI: 10.1177/1756283X16656735] [Cited by in Crossref: 80] [Cited by in F6Publishing: 40] [Article Influence: 16.0] [Reference Citation Analysis]
67 Oudry J, Chen J, Glaser KJ, Miette V, Sandrin L, Ehman RL. Cross-validation of magnetic resonance elastography and ultrasound-based transient elastography: a preliminary phantom study. J MagnReson Imaging. 2009;30:1145-1150. [PMID: 19856447 DOI: 10.1002/jmri.21929] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
68 Lee DH. Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease. Endocrinol Metab (Seoul) 2020;35:243-59. [PMID: 32615709 DOI: 10.3803/EnM.2020.35.2.243] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
69 Chen CC, Hsu HT, Chen YL, Chen RC, Wu WP, Chou CT. Diagnostic Accuracy of Acoustic Radiation Force Impulse (ARFI) and Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein (WFA⁺-M2BP) in Patients with Chronic Liver Disease. Med Sci Monit 2019;25:7169-74. [PMID: 31548540 DOI: 10.12659/MSM.916533] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Yoon KT, Lim SM, Park JY, Kim do Y, Ahn SH, Han KH, Chon CY, Cho M, Lee JW, Kim SU. Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation. Dig Dis Sci. 2012;57:1682-1691. [PMID: 22302243 DOI: 10.1007/s10620-012-2044-4] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 7.6] [Reference Citation Analysis]
71 Trifan A, Stanciu C. Checkmate to liver biopsy in chronic hepatitis C? World J Gastroenterol 2012; 18(39): 5514-5520 [PMID: 23112543 DOI: 10.3748/wjg.v18.i39.5514] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
72 Kinner S, Reeder SB, Yokoo T. Quantitative Imaging Biomarkers of NAFLD. Dig Dis Sci. 2016;61:1337-1347. [PMID: 26848588 DOI: 10.1007/s10620-016-4037-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
73 Caussy C, Alquiraish MH, Nguyen P, Hernandez C, Cepin S, Fortney LE, Ajmera V, Bettencourt R, Collier S, Hooker J, Sy E, Rizo E, Richards L, Sirlin CB, Loomba R. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology. 2018;67:1348-1359. [PMID: 29108123 DOI: 10.1002/hep.29639] [Cited by in Crossref: 108] [Cited by in F6Publishing: 104] [Article Influence: 36.0] [Reference Citation Analysis]
74 Jeong JY, Sohn JH, Sohn W, Park CH, Kim TY, Jun DW, Kim Y, Jeong WK. Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B. Gut Liver. 2017;11:852-859. [PMID: 28651307 DOI: 10.5009/gnl16521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
75 Rawlins SR, Mullen CM, Simon HM, Kim T, Landas SK, Walser MS, Levine RA. Wedge and needle liver biopsies show discordant histopathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. Gastroenterol Rep (Oxf) 2013;1:51-7. [PMID: 24759667 DOI: 10.1093/gastro/got006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
76 Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 2011;21:87-97. [PMID: 20680289 DOI: 10.1007/s00330-010-1905-5] [Cited by in Crossref: 285] [Cited by in F6Publishing: 264] [Article Influence: 25.9] [Reference Citation Analysis]
77 Fu J, Wu B, Wu H, Lin F, Deng W. Accuracy of real-time shear wave elastography in staging hepatic fibrosis: a meta-analysis. BMC Med Imaging 2020;20:16. [PMID: 32046659 DOI: 10.1186/s12880-020-0414-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
78 Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, Munteanu M, Massard J, Benhamou Y, Ratziu V. Assessment of liver fibrosis: noninvasive means. Saudi J Gastroenterol. 2008;14:163-173. [PMID: 19568532 DOI: 10.4103/1319-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Tajiri K, Kawai K, Sugiyama T. Strain elastography for assessment of liver fibrosis and prognosis in patients with chronic liver diseases. J Gastroenterol 2017;52:724-33. [PMID: 27787686 DOI: 10.1007/s00535-016-1277-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
80 Kim SU, Lee JH, Kim DY, Ahn SH, Jung KS, Choi EH, Park YN, Han KH, Chon CY, Park JY. Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS One. 2012;7:e36676. [PMID: 22574212 DOI: 10.1371/journal.pone.0036676] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 7.8] [Reference Citation Analysis]
81 Li C, Hu J, Zhou D, Zhao J, Ma K, Yin X, Wang J. Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging. BMC Cancer. 2014;14:590. [PMID: 25123782 DOI: 10.1186/1471-2407-14-590] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
82 Cai S, Ou Z, Liu D, Liu L, Liu Y, Wu X, Yu T, Peng J. Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome. United European Gastroenterol J. 2018;6:558-566. [PMID: 29881611 DOI: 10.1177/2050640617751252] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 8.7] [Reference Citation Analysis]
83 Villani R, Cavallone F, Romano AD, Bellanti F, Serviddio G. Two-Dimensional Shear Wave Elastography versus Transient Elastography: A Non-Invasive Comparison for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C. Diagnostics (Basel) 2020;10:E313. [PMID: 32429410 DOI: 10.3390/diagnostics10050313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Song J, da Costa KA, Fischer LM, Kohlmeier M, Kwock L, Wang S, Zeisel SH. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J. 2005;19:1266-1271. [PMID: 16051693 DOI: 10.1096/fj.04-3580com] [Cited by in Crossref: 152] [Cited by in F6Publishing: 148] [Article Influence: 10.1] [Reference Citation Analysis]
85 Sharma P, Dhawan S, Bansal R, Tyagi P, Bansal N, Singla V, Kumar A, Matin A, Arora A. Usefulness of transient elastography by FibroScan for the evaluation of liver fibrosis. Indian J Gastroenterol. 2014;33:445-451. [PMID: 25138787 DOI: 10.1007/s12664-014-0491-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
86 Koon CM, Zhang X, Chen W, Chu ES, San Lau CB, Wáng YX. Black blood T1rho MR imaging may diagnose early stage liver fibrosis: a proof-of-principle study with rat biliary duct ligation model. Quant Imaging Med Surg 2016;6:353-63. [PMID: 27709071 DOI: 10.21037/qims.2016.08.11] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
87 Riley TR 3rd, Ruggiero FM. The effect of processing on liver biopsy core size. Dig Dis Sci 2008;53:2775-7. [PMID: 18270834 DOI: 10.1007/s10620-007-0181-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
88 Lo Re V 3rd, Kostman JR, Amorosa VK. Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century. Clin Liver Dis 2008;12:587-609, ix. [PMID: 18625430 DOI: 10.1016/j.cld.2008.03.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
89 Lee BW, Lee YH, Park CY, Rhee EJ, Lee WY, Kim NH, Choi KM, Park KG, Choi YK, Cha BS, Lee DH; Korean Diabetes Association (KDA) Fatty Liver Research Group. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. Diabetes Metab J 2020;44:382-401. [PMID: 32431115 DOI: 10.4093/dmj.2020.0010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
90 Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology. 2013;268:411-419. [PMID: 23564711 DOI: 10.1148/radiol.13121193] [Cited by in Crossref: 152] [Cited by in F6Publishing: 141] [Article Influence: 19.0] [Reference Citation Analysis]
91 Fu Y, Peng HJ, Zhang X, Peng WJ, Wu J, Wang SP, Du M, Li RM. Assessment of fibrotic tissue and microvascular architecture by in-line phase-contrast imaging in a mouse model of liver fibrosis. Eur Radiol 2016;26:2947-55. [PMID: 26787604 DOI: 10.1007/s00330-015-4173-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
92 Jeong JY, Cho YS, Sohn JH. Role of two-dimensional shear wave elastography in chronic liver diseases: A narrative review. World J Gastroenterol 2018; 24(34): 3849-3860 [PMID: 30228779 DOI: 10.3748/wjg.v24.i34.3849] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
93 Sajjad S, Garcia M, Malik A, Van Thiel DH. An assessment of the accuracy of hepatic and splenic size based upon a clinician's physical examination, a radiologist's impression and the actual liver and spleen volumes calculated by CT scanning. Dig Dis Sci 2008;53:1946-50. [PMID: 18320318 DOI: 10.1007/s10620-007-0087-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
94 Ueno T, Kodama T, Noguchi Y, Nomura M, Saka R, Takama Y, Tazuke Y, Bessho K, Okuyama H. Serum Mac-2-binding protein (M2BPGi) as a marker of chronological liver fibrosis in biliary atresia patients with cirrhosis. Pediatr Surg Int. 2019;35:1065-1070. [PMID: 31392502 DOI: 10.1007/s00383-019-04535-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Mirza MS. Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease. ISRN Gastroenterol. 2011;2011:592404. [PMID: 21991518 DOI: 10.5402/2011/592404] [Cited by in Crossref: 63] [Cited by in F6Publishing: 72] [Article Influence: 6.3] [Reference Citation Analysis]
96 Mehta SH, Lau B, Afdhal NH, Thomas DL. Exceeding the limits of liver histology markers. J Hepatol. 2009;50:36-41. [PMID: 19012989 DOI: 10.1016/j.jhep.2008.07.039] [Cited by in Crossref: 180] [Cited by in F6Publishing: 174] [Article Influence: 13.8] [Reference Citation Analysis]
97 Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Yama T, Tanaka J. Long-term prognosis of patients with chronic hepatitis C who did not receive interferon-based therapy: causes of death and analysis based on the FIB-4 index. J Gastroenterol 2016;51:380-9. [DOI: 10.1007/s00535-015-1117-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
98 Lee WJ, Uradomo LT, Zhang Y, Twaddell W, Darwin P. Comparison of the Diagnostic Yield of EUS Needles for Liver Biopsy: Ex Vivo Study. Diagn Ther Endosc 2017;2017:1497831. [PMID: 29056843 DOI: 10.1155/2017/1497831] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
99 Kuo YH, Lu SN, Hung CH, Kee KM, Chen CH, Hu TH, Lee CM, Changchien CS, Wang JH. Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis. Hepatol Int 2010;4:700-6. [PMID: 21286340 DOI: 10.1007/s12072-010-9223-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
100 Attallah AM, El-Far M, Omran MM, Farid K, Albannan MS, El-Dosoky I. Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients. J Clin Lab Anal 2013;27:121-9. [PMID: 23460258 DOI: 10.1002/jcla.21572] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
101 Dulai PS, Sirlin CB, Loomba R. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. J Hepatol. 2016;65:1006-1016. [PMID: 27312947 DOI: 10.1016/j.jhep.2016.06.005] [Cited by in Crossref: 176] [Cited by in F6Publishing: 162] [Article Influence: 35.2] [Reference Citation Analysis]
102 Runge JH, Akkerman EM, Troelstra MA, Nederveen AJ, Beuers U, Stoker J. Comparison of clinical MRI liver iron content measurements using signal intensity ratios, R 2 and R 2. Abdom Radiol (NY) 2016;41:2123-31. [PMID: 27431019 DOI: 10.1007/s00261-016-0831-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
103 Levien AS, Weisse C, Donovan TA, Berent AC. Assessment of the efficacy and potential complications of transjugular liver biopsy in canine cadavers. J Vet Intern Med 2014;28:338-45. [PMID: 24765677 DOI: 10.1111/jvim.12305] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
104 孙蓓, 李用国, 兰英华. Fibroscan在慢性肝病诊治中的应用进展. 世界华人消化杂志 2015; 23(9): 1433-1439 [DOI: 10.11569/wcjd.v23.i9.1433] [Reference Citation Analysis]
105 Foucher J, Chanteloup E, Vergniol J, Castéra L, Le Bail B, Adhoute X, Bertet J, Couzigou P, de Lédinghen V. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55:403-408. [PMID: 16020491 DOI: 10.1136/gut.2005.069153] [Cited by in Crossref: 840] [Cited by in F6Publishing: 796] [Article Influence: 52.5] [Reference Citation Analysis]
106 Tripodi A, Chantarangkul V, Primignani M, Clerici M, Dell'era A, Aghemo A, Mannucci PM. Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma. Intern Emerg Med. 2012;7:139-144. [PMID: 21298360 DOI: 10.1007/s11739-011-0528-4] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
107 Corey KE, Klebanoff MJ, Tramontano AC, Chung RT, Hur C. Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis. Dig Dis Sci 2016;61:2108-17. [PMID: 26825843 DOI: 10.1007/s10620-016-4044-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
108 Castro R, Perazzo H, Grinsztejn B, Veloso VG, Hyde C. Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective. Int J Hepatol. 2015;2015:852968. [PMID: 26693356 DOI: 10.1155/2015/852968] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
109 Takyar V, Surana P, Kleiner DE, Wilkins K, Hoofnagle JH, Liang TJ, Heller T, Koh C. Noninvasive markers for staging fibrosis in chronic delta hepatitis. Aliment Pharmacol Ther. 2017;45:127-138. [PMID: 27813124 DOI: 10.1111/apt.13834] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
110 Park MS, Kim BK, Cheong JY, Kim DJ, Park JY, Kim do Y, Ahn SH, Han KH, Chon CY, Kim SU. Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B. PLoS One. 2013;8:e55759. [PMID: 23405210 DOI: 10.1371/journal.pone.0055759] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
111 Gheonea DI, Săftoiu A, Ciurea T, Gorunescu F, Iordache S, Popescu GL, Belciug S, Gorunescu M, Săndulescu L. Real-time sono-elastography in the diagnosis of diffuse liver diseases. World J Gastroenterol 2010; 16(14): 1720-1726 [PMID: 20380003 DOI: 10.3748/wjg.v16.i14.1720] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
112 Lee SH, Shin HP, Lee JI. Real-world single-center experience with direct-acting antivirals for improvement of the liver fibrosis after chronic hepatitis C treatment. Antivir Chem Chemother 2020;28:2040206620974835. [PMID: 33215505 DOI: 10.1177/2040206620974835] [Reference Citation Analysis]
113 Cho HJ, Kim SS, Ahn SJ, Park JH, Kim DJ, Kim YB, Cho SW, Cheong JY. Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B. Clin Mol Hepatol. 2014;20:347-354. [PMID: 25548740 DOI: 10.3350/cmh.2014.20.4.347] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
114 Laursen TL, Sandahl TD, Kazankov K, George J, Grønbæk H. Liver-related effects of chronic hepatitis C antiviral treatment. World J Gastroenterol 2020; 26(22): 2931-2947 [PMID: 32587440 DOI: 10.3748/wjg.v26.i22.2931] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
115 Khalifa A, Lewin DN, Sasso R, Rockey DC. The Utility of Liver Biopsy in the Evaluation of Liver Disease and Abnormal Liver Function Tests. Am J Clin Pathol 2021;156:259-67. [PMID: 33693456 DOI: 10.1093/ajcp/aqaa225] [Reference Citation Analysis]
116 Chen S, Liao B, Zhong Z, Zheng Y, Liu B, Shan Q, Xie X, Zhou L. Supersonic shearwave elastography in the assessment of liver fibrosis for postoperative patients with biliary atresia. Sci Rep. 2016;6:31057. [PMID: 27511435 DOI: 10.1038/srep31057] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
117 Saoi M, Britz-McKibbin P. New Advances in Tissue Metabolomics: A Review. Metabolites 2021;11:672. [PMID: 34677387 DOI: 10.3390/metabo11100672] [Reference Citation Analysis]
118 Hines CD, Bley TA, Lindstrom MJ, Reeder SB. Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Reson Imaging. 2010;31:725-731. [PMID: 20187219 DOI: 10.1002/jmri.22066] [Cited by in Crossref: 108] [Cited by in F6Publishing: 98] [Article Influence: 9.8] [Reference Citation Analysis]
119 Surana P, Kapuria D, Broadwell C, Wright EC, Takyar V, Kleiner DE, Ghany MG, Ben-Yakov G, Heller T, Liang TJ, Koh C. Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years. Antiviral Res 2019;168:61-7. [PMID: 31125632 DOI: 10.1016/j.antiviral.2019.05.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
120 McCarty TR, Bazarbashi AN, Njei B, Ryou M, Aslanian HR, Muniraj T. Endoscopic Ultrasound-Guided, Percutaneous, and Transjugular Liver Biopsy: A Comparative Systematic Review and Meta-Analysis. Clin Endosc 2020;53:583-93. [PMID: 33027584 DOI: 10.5946/ce.2019.211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
121 Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging 2011;34:729-49. [PMID: 22025886 DOI: 10.1002/jmri.22775] [Cited by in Crossref: 434] [Cited by in F6Publishing: 197] [Article Influence: 43.4] [Reference Citation Analysis]
122 Bharwani N, Koh DM. Diffusion-weighted imaging of the liver: an update. Cancer Imaging 2013;13:171-85. [PMID: 23598460 DOI: 10.1102/1470-7330.2013.0019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
123 Sato S, Genda T, Ichida T, Amano N, Sato S, Murata A, Tsuzura H, Narita Y, Kanemitsu Y, Hirano K, Shimada Y, Iijima K, Wada R, Nagahara A, Watanabe S. Prediction of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication Using Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein. Int J Mol Sci. 2016;17. [PMID: 27999409 DOI: 10.3390/ijms17122143] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
124 Venkatesh SK, Wells ML, Miller FH, Jhaveri KS, Silva AC, Taouli B, Ehman RL. Magnetic resonance elastography: beyond liver fibrosis-a case-based pictorial review. Abdom Radiol (NY) 2018;43:1590-611. [PMID: 29143076 DOI: 10.1007/s00261-017-1383-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
125 Reeder SB, Sirlin CB. Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am. 2010;18:337-357, ix. [PMID: 21094444 DOI: 10.1016/j.mric.2010.08.013] [Cited by in Crossref: 172] [Cited by in F6Publishing: 156] [Article Influence: 17.2] [Reference Citation Analysis]
126 Bremner KE, Bayoumi AM, Sherman M, Krahn MD. Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis. Can J Gastroenterol 2007;21:491-500. [PMID: 17703248 DOI: 10.1155/2007/182383] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
127 Zhang GM, Xia YJ. Reference Intervals of Fibrosis Index Based on Four Indicators in Healthy Elderly Chinese. J Clin Lab Anal 2016;30:645-8. [PMID: 26953257 DOI: 10.1002/jcla.21916] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
128 Venkatesh SK, Wang G, Lim SG, Wee A. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur Radiol. 2014;24:70-78. [PMID: 23928932 DOI: 10.1007/s00330-013-2978-8] [Cited by in Crossref: 111] [Cited by in F6Publishing: 106] [Article Influence: 13.9] [Reference Citation Analysis]
129 Omran D, Yosry A, Darweesh SK, Nabeel MM, El-Beshlawey M, Saif S, Fared A, Hassany M, Zayed RA. Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients. Clin Exp Med 2018;18:45-50. [PMID: 28567544 DOI: 10.1007/s10238-017-0463-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
130 Yang ZX, Liang HY, Hu XX, Huang YQ, Ding Y, Yang S, Zeng MS, Rao SX. Feasibility of histogram analysis of susceptibility-weighted MRI for staging of liver fibrosis. Diagn Interv Radiol 2016;22:301-7. [PMID: 27113421 DOI: 10.5152/dir.2016.15284] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
131 Gonzalez HC, Duarte-Rojo A. Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes. Curr Gastroenterol Rep 2016;18:32. [PMID: 27177638 DOI: 10.1007/s11894-016-0508-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
132 Wang D, Wang Q, Shan F, Liu B, Lu C. Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers. BMC Infect Dis. 2010;10:251. [PMID: 20735842 DOI: 10.1186/1471-2334-10-251] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
133 Li Y, Chen Y, Zhao Y. The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis. PLoS One. 2014;9:e105728. [PMID: 25165830 DOI: 10.1371/journal.pone.0105728] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
134 Lee MH, Cheong JY, Um SH, Seo YS, Kim DJ, Hwang SG, Yang JM, Han KH, Cho SW. Comparison of surrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis in patients with chronic viral hepatitis. Dig Dis Sci. 2010;55:3552-3560. [PMID: 20428950 DOI: 10.1007/s10620-010-1219-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
135 Liu YR, Lin BB, Zeng DW, Zhu YY, Chen J, Zheng Q, Dong J, Jiang JJ. Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B. BMC Gastroenterol 2014;14:145. [PMID: 25128299 DOI: 10.1186/1471-230X-14-145] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
136 Valva P, Casciato P, Lezama C, Galoppo M, Gadano A, Galdame O, Galoppo MC, Mullen E, De Matteo E, Preciado MV. Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children. PLoS One. 2013;8:e53519. [PMID: 23326448 DOI: 10.1371/journal.pone.0053519] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
137 Alkhouri N, Mansoor S, Giammaria P, Liccardo D, Lopez R, Nobili V. The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease. PLoS One. 2014;9:e104558. [PMID: 25121514 DOI: 10.1371/journal.pone.0104558] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
138 Vijayaraghavan GR, David S, Bermudez-Allende M, Sarwat H. Imaging-guided Parenchymal Liver Biopsy: How We Do It. J Clin Imaging Sci 2011;1:30. [PMID: 21966627 DOI: 10.4103/2156-7514.82082] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
139 Patel HK, Saxena R, Rush N, Patel SK, Dasari CS, Mneimneh W, Quickery A, Rahal MA, Temnykh L, DeWitt J, Al-Haddad M. A Comparative Study of 22G versus 19G Needles for EUS-Guided Biopsies for Parenchymal Liver Disease: Are Thinner Needles Better? Dig Dis Sci 2021;66:238-46. [PMID: 32128647 DOI: 10.1007/s10620-020-06165-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
140 Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, Ratziu V, Mercadier A, Benhamou Y, Hainque B. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol. 2004;3:8. [PMID: 15387887 DOI: 10.1186/1476-5926-3-8] [Cited by in Crossref: 239] [Cited by in F6Publishing: 247] [Article Influence: 14.1] [Reference Citation Analysis]
141 Dioguardi N, Franceschini B, Russo C, Grizzi F. Computer-aided morphometry of liver inflammation in needle biopsies. World J Gastroenterol 2005;11:6995-7000. [PMID: 16437605 DOI: 10.3748/wjg.v11.i44.6995] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
142 Bhogal N, Lamb B, Arbeiter B, Malik S, Sayles H, Lazenby AJ, Chandan S, Dhaliwal A, Singh S, Bhat I. Safety and adequacy of endoscopic ultrasound-guided random liver biopsy in comparison with transjugular and percutaneous approaches. Endosc Int Open. 2020;8:E1850-E1854. [PMID: 33269320 DOI: 10.1055/a-1274-9763] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
143 Arulanandan A, Loomba R. Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet? Curr Hepatol Rep 2015;14:109-18. [PMID: 26500833 DOI: 10.1007/s11901-015-0263-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
144 Connoley D, Patel PJ, Hogan B, Tanwar S, Rhodes F, Parkes J, Burt A, Watkins J, Sievert W, Rosenberg W. The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study. BMC Gastroenterol 2021;21:268. [PMID: 34182924 DOI: 10.1186/s12876-021-01795-5] [Reference Citation Analysis]
145 Xu H, Kong W, Liu L, Chi X, Wang X, Wu R, Gao X, Wang H, Qu L, Qi Y, Pan Y, Niu J. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C. BMC Gastroenterol 2017;17:62. [PMID: 28486931 DOI: 10.1186/s12876-017-0618-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
146 Quezada N, León F, Martínez J, Jarufe N, Guerra JF. Emergency right hepatectomy after laparoscopic tru-cut liver biopsy. Int J Surg Case Rep 2015;8C:42-4. [PMID: 25618399 DOI: 10.1016/j.ijscr.2015.01.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
147 Toshima T, Shirabe K, Takeishi K, Motomura T, Mano Y, Uchiyama H, Yoshizumi T, Soejima Y, Taketomi A, Maehara Y. New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver. J Gastroenterol. 2011;46:705-711. [PMID: 21264479 DOI: 10.1007/s00535-010-0365-7] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 8.6] [Reference Citation Analysis]
148 Keller LM, Eighmy S, Li C, Winter L, Kerecman J, Goodman Z, Mittal N, Blanco CL. Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp. PLoS One 2020;15:e0228985. [PMID: 32150543 DOI: 10.1371/journal.pone.0228985] [Reference Citation Analysis]
149 Chung JH, Ahn HS, Kim SG, Lee YN, Kim YS, Jeong SW, Jang JY, Lee SH, Kim HS, Kim BS. The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis. Clin Mol Hepatol. 2013;19:156-164. [PMID: 23837140 DOI: 10.3350/cmh.2013.19.2.156] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
150 Lu YP, Wei J, Xu LR, Tang YY, Yuan Y, Zhang Y, Li YY. Assessment of fibrosis during the development of fatty liver in rabbits using real-time shear-wave elastography. J Huazhong Univ Sci Technolog Med Sci 2014;34:921-8. [PMID: 25480592 DOI: 10.1007/s11596-014-1375-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
151 Wang L, Yao M, Liu S, Yang D, Wen X, Ning J, Wang L, Zhou G, Xu Q, Chen X, Zhao J, Lu F. Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis. Dis Markers 2020;2020:6036904. [PMID: 32089754 DOI: 10.1155/2020/6036904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
152 Behera MK, Shukla SK, Dixit VK, Nath P, Abhilash VB, Asati PK, Jain AK. Effect of vitamin D supplementation on sustained virological response in genotype 1/4 chronic hepatitis C treatment-naïve patients from India. Indian J Med Res 2018;148:200-6. [PMID: 30381543 DOI: 10.4103/ijmr.IJMR_1295_15] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
153 Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A. Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C. Sci Rep. 2017;7:46705. [PMID: 28425454 DOI: 10.1038/srep46705] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
154 Engelmann G, Gebhardt C, Wenning D, Wühl E, Hoffmann GF, Selmi B, Grulich-Henn J, Schenk JP, Teufel U. Feasibility study and control values of transient elastography in healthy children. Eur J Pediatr. 2012;171:353-360. [PMID: 21861093 DOI: 10.1007/s00431-011-1558-7] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 8.9] [Reference Citation Analysis]
155 Dhole SD, Kher AS, Ghildiyal RG, Tambse MP. Chronic Liver Diseases in Children: Clinical Profile and Histology. J Clin Diagn Res 2015;9:SC04-7. [PMID: 26393179 DOI: 10.7860/JCDR/2015/13383.6250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
156 Sun D, Willingham C, Durrani A, King P, Cleary K, Wood B. A novel end-effector design for robotics in image-guided needle procedures. Int J Med Robot 2006;2:91-7. [PMID: 17520618 DOI: 10.1002/rcs.66] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
157 Spycher C, Zimmermann A, Reichen J. The diagnostic value of liver biopsy. BMC Gastroenterol 2001;1:12. [PMID: 11707153 DOI: 10.1186/1471-230x-1-12] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
158 Kim HJ, Lee HK, Cho JH, Yang HJ. Quantitative comparison of transient elastography (TE), shear wave elastography (SWE) and liver biopsy results of patients with chronic liver disease. J Phys Ther Sci 2015;27:2465-8. [PMID: 26357427 DOI: 10.1589/jpts.27.2465] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
159 Mehta SH, Kirk GD, Astemborski J, Sulkowski MS, Afdhal NH, Thomas DL. Stability of liver fibrosis among HCV-infected injection drug users. Antivir Ther 2012;17:813-21. [PMID: 22418880 DOI: 10.3851/IMP2085] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
160 Sagir A, Glaubach B, Sahin K, Graf D, Erhardt A, Oette M, Häussinger D. Transient Elastography for the Detection of Liver Damage in Patients with HIV. Infect Dis Ther 2015;4:355-64. [PMID: 26143457 DOI: 10.1007/s40121-015-0073-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
161 Perazzo H, Cardoso SW, Yanavich C, Nunes EP, Morata M, Gorni N, da Silva PS, Cardoso C, Almeida C, Luz P, Veloso VG, Grinsztejn B. Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy. J Int AIDS Soc. 2018;21:e25201. [PMID: 30394678 DOI: 10.1002/jia2.25201] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
162 Koh H, Kim S, Kim MJ, Kim HG, Shin HJ, Lee MJ. Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis. World J Gastroenterol 2015; 21(33): 9741-9748 [PMID: 26361421 DOI: 10.3748/wjg.v21.i33.9741] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
163 Pirmoazen AM, Khurana A, El Kaffas A, Kamaya A. Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease. Theranostics 2020;10:4277-89. [PMID: 32226553 DOI: 10.7150/thno.40249] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
164 Wang Y, Yu W, Shen C, Wang W, Zhang L, Liu F, Sun H, Zhao Y, Che H, Zhao C. Predictive Value of Serum IFN-γ inducible Protein-10 and IFN-γ/IL-4 Ratio for Liver Fibrosis Progression in CHB Patients. Sci Rep 2017;7:40404. [PMID: 28067328 DOI: 10.1038/srep40404] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
165 Sadler MD, Crotty P, Fatovich L, Wilson S, Rabin HR, Myers RP. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis. Can J Gastroenterol Hepatol. 2015;29:139-144. [PMID: 25855877 DOI: 10.1155/2015/138530] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
166 Singh S, Venkatesh SK, Keaveny A, Adam S, Miller FH, Asbach P, Godfrey EM, Silva AC, Wang Z, Murad MH, Asrani SK, Lomas DJ, Ehman RL. Diagnostic accuracy of magnetic resonance elastography in liver transplant recipients: A pooled analysis. Ann Hepatol 2016;15:363-76. [PMID: 27049490 DOI: 10.5604/16652681.1198808] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
167 Abdollahi M, Pouri A, Ghojazadeh M, Estakhri R, Somi M. Non-invasive serum fibrosis markers: A study in chronic hepatitis. Bioimpacts. 2015;5:17-23. [PMID: 25901293 DOI: 10.15171/bi.2015.05] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
168 Zhang H, Yan XL, Guo XX, Shi MJ, Lu YY, Zhou QM, Chen QL, Hu YY, Xu LM, Huang S, Su SB. MiR-27a as a predictor for the activation of hepatic stellate cells and hepatitis B virus-induced liver cirrhosis. Oncotarget. 2018;9:1075-1090. [PMID: 29416678 DOI: 10.18632/oncotarget.23262] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
169 Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, Clark L, Hooker J, Chavez T, Ang BD, Middleton MS, Peterson M, Loomba R, Sirlin CB. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 2015;274:416-25. [PMID: 25247408 DOI: 10.1148/radiol.14140754] [Cited by in Crossref: 131] [Cited by in F6Publishing: 117] [Article Influence: 18.7] [Reference Citation Analysis]
170 Mobarak L, Nabeel MM, Hassan E, Omran D, Zakaria Z. Real-time elastography as a noninvasive assessment of liver fibrosis in chronic hepatitis C Egyptian patients: a prospective study. Ann Gastroenterol. 2016;29:358-362. [PMID: 27366038 DOI: 10.20524/aog.2016.0033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
171 Fujii H, Enomoto M, Fukumoto S, Kimura T, Nadatani Y, Takashima S, Hagihara A, Uchida-Kobayashi S, Tamori A, Nishimoto N, Kawada N. Validation of a two-step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis. JGH Open 2021;5:801-8. [PMID: 34263075 DOI: 10.1002/jgh3.12590] [Reference Citation Analysis]
172 Pembroke T, Gallimore A, Godkin A. Tracking the kinetics of intrahepatic immune responses by repeated fine needle aspiration of the liver. J Immunol Methods 2015;424:131-5. [PMID: 25914090 DOI: 10.1016/j.jim.2015.04.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
173 Abdo AA, Al Swat K, Azzam N, Ahmed S, Al Faleh F. Validation of three noninvasive laboratory variables to predict significant fibrosis and cirrhosis in patients with chronic hepatitis C in Saudi Arabia. Ann Saudi Med 2007;27:89-93. [PMID: 17356320 DOI: 10.5144/0256-4947.2007.89] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
174 Kumar M, Rastogi A, Singh T, Bihari C, Gupta E, Sharma P, Garg H, Kumar R, Bhatia V, Tyagi P, Sarin SK. Analysis of discordance between transient elastography and liver biopsy for assessing liver fibrosis in chronic hepatitis B virus infection. Hepatol Int. 2013;7:134-143. [PMID: 26201627 DOI: 10.1007/s12072-012-9380-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
175 Dugum M, McCullough A. Diagnosis and Management of Alcoholic Liver Disease. J Clin Transl Hepatol 2015;3:109-16. [PMID: 26356792 DOI: 10.14218/JCTH.2015.00008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
176 Takyar V, Etzion O, Heller T, Kleiner DE, Rotman Y, Ghany MG, Fryzek N, Williams VH, Rivera E, Auh S, Liang TJ, Hoofnagle JH, Koh C. Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience. Aliment Pharmacol Ther 2017;45:744-53. [PMID: 28074540 DOI: 10.1111/apt.13939] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
177 Dillman JR, Heider A, Bilhartz JL, Smith EA, Keshavarzi N, Rubin JM, Lopez MJ. Ultrasound shear wave speed measurements correlate with liver fibrosis in children. Pediatr Radiol. 2015;45:1480-1488. [PMID: 25851300 DOI: 10.1007/s00247-015-3345-5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 7.3] [Reference Citation Analysis]
178 Lambrecht J, Jan Poortmans P, Verhulst S, Reynaert H, Mannaerts I, van Grunsven LA. Circulating ECV-Associated MiRNA s as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis. Front Pharmacol. 2017;8:56. [PMID: 28232800 DOI: 10.3389/fphar.2017.00056] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
179 Huwart L, Salameh N, ter Beek L, Vicaut E, Peeters F, Sinkus R, Van Beers BE. MR elastography of liver fibrosis: preliminary results comparing spin-echo and echo-planar imaging. Eur Radiol. 2008;18:2535-2541. [PMID: 18504591 DOI: 10.1007/s00330-008-1051-5] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
180 Sumer S, Aktug Demir N, Kölgelier S, Cagkan Inkaya A, Arpaci A, Saltuk Demir L, Ural O. The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis. Hepat Mon. 2013;13:e10106. [PMID: 24032040 DOI: 10.5812/hepatmon.10106] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
181 Xu X, Su Y, Song R, Sheng Y, Ai W, Wu X, Liu H. Performance of transient elastography assessing fibrosis of single hepatitis B virus infection: a systematic review and meta-analysis of a diagnostic test. Hepatol Int. 2015;9:558-566. [PMID: 26187292 DOI: 10.1007/s12072-015-9643-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
182 Kamada Y, Ono M, Hyogo H, Fujii H, Sumida Y, Yamada M, Mori K, Tanaka S, Maekawa T, Ebisutani Y, Yamamoto A, Takamatsu S, Yoneda M, Kawada N, Chayama K, Saibara T, Takehara T, Miyoshi E; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG‐NAFLD). Use of Mac-2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis. Hepatol Commun 2017;1:780-91. [PMID: 29404494 DOI: 10.1002/hep4.1080] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
183 Wang D, Wang L, Wang Z, Chen S, Ni Y, Jiang D. Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis. Lipids Health Dis 2018;17:67. [PMID: 29615042 DOI: 10.1186/s12944-018-0720-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
184 Felicani C, De Molo C, Stefanescu H, Conti F, Mazzotta E, Gabusi V, Nardi E, Morselli-Labate AM, Andreone P, Serra C. Point quantification elastography in the evaluation of liver elasticity in healthy volunteers: a reliability study based on operator expertise. J Ultrasound 2018;21:89-98. [PMID: 29790083 DOI: 10.1007/s40477-018-0300-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
185 Xie Q, Zhou X, Huang P, Wei J, Wang W, Zheng S. The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis. PLoS One. 2014;9:e92772. [PMID: 24736610 DOI: 10.1371/journal.pone.0092772] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
186 Cholongitas E, Quaglia A, Samonakis D, Senzolo M, Triantos C, Patch D, Leandro G, Dhillon AP, Burroughs AK. Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut. 2006;55:1789-1794. [PMID: 16636018 DOI: 10.1136/gut.2005.090415] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 5.2] [Reference Citation Analysis]
187 Lee HW, Park SY, Kim SU, Jang JY, Park H, Kim JK, Lee CK, Chon YE, Han KH. Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease. PLoS One. 2016;11:e0157358. [PMID: 27284700 DOI: 10.1371/journal.pone.0157358] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 7.6] [Reference Citation Analysis]
188 Engelmann G, Gebhardt C, Wenning D, Wühl E, Hoffmann GF, Selmi B, Grulich-Henn J, Schenk JP, Teufel U. Feasibility study and control values of transient elastography in healthy children. Eur J Pediatr 2012;171:353-60. [PMID: 21861093 DOI: 10.1007/s00431-011-1558-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
189 Yoon JH, Lee JM, Woo HS, Yu MH, Joo I, Lee ES, Sohn JY, Lee KB, Han JK, Choi BI. Staging of hepatic fibrosis: comparison of magnetic resonance elastography and shear wave elastography in the same individuals. Korean J Radiol. 2013;14:202-212. [PMID: 23483022 DOI: 10.3348/kjr.2013.14.2.202] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
190 Nierhoff J, Chávez Ortiz AA, Herrmann E, Zeuzem S, Friedrich-rust M. The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis. Eur Radiol 2013;23:3040-53. [DOI: 10.1007/s00330-013-2927-6] [Cited by in Crossref: 120] [Cited by in F6Publishing: 103] [Article Influence: 15.0] [Reference Citation Analysis]
191 Zhao F, Yuan J, Deng M, Lu PX, Ahuja AT, Wang YX. Further exploration of MRI techniques for liver T1rho quantification. Quant Imaging Med Surg 2013;3:308-15. [PMID: 24404445 DOI: 10.3978/j.issn.2223-4292.2013.12.10] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
192 Kim YD, Song D, Heo JH, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Kim KJ, Han KH. Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography. PLoS One 2015;10:e0139227. [PMID: 26421848 DOI: 10.1371/journal.pone.0139227] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
193 Joshita S, Umemura T, Usami Y, Yamashita Y, Norman GL, Sugiura A, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Yoshizawa K, Ota M, Tanaka E. Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis. Sci Rep 2018;8:8159. [PMID: 29802350 DOI: 10.1038/s41598-018-26531-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
194 Stankovic Z. Four-dimensional flow magnetic resonance imaging in cirrhosis. World J Gastroenterol 2016; 22(1): 89-102 [PMID: 26755862 DOI: 10.3748/wjg.v22.i1.89] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
195 Khatun M, Ray RB. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis. Cells 2019;8:E1249. [PMID: 31615075 DOI: 10.3390/cells8101249] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 21.5] [Reference Citation Analysis]
196 Tapper EB, Hunink MG, Afdhal NH, Lai M, Sengupta N. Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score. PLoS One 2016;11:e0147237. [PMID: 26905872 DOI: 10.1371/journal.pone.0147237] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
197 Huang WS, Lin PY, Chin CC, Yeh CH, Hsieh CC, Chang TS, Wang JY. Stapled hemorrhoidopexy for prolapsed hemorrhoids in patients with liver cirrhosis; a preliminary outcome for 8-case experience. Int J Colorectal Dis 2007;22:1083-9. [PMID: 17334772 DOI: 10.1007/s00384-007-0271-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
198 Bugeac N, Pacht A, Mandel H, Iancu T, Tamir A, Srugo I, Shaoul R. The significance of isolated elevation of serum aminotransferases in infants and young children. Arch Dis Child. 2007;92:1109-1112. [PMID: 17652319 DOI: 10.1136/adc.2007.121194] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
199 Kim SU, Kim JK, Park YN, Han KH. Discordance between liver biopsy and Fibroscan® in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammation. PLoS One. 2012;7:e32233. [PMID: 22384189 DOI: 10.1371/journal.pone.0032233] [Cited by in Crossref: 31] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
200 Ulitsky A, Ananthakrishnan AN, Komorowski R, Wallace J, Surapaneni SN, Franco J, Saeian K, Gawrieh S. A Noninvasive Clinical Scoring Model Predicts Risk of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. OBES SURG 2010;20:685-91. [DOI: 10.1007/s11695-010-0118-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
201 Wang Y, Ganger DR, Levitsky J, Sternick LA, McCarthy RJ, Chen ZE, Fasanati CW, Bolster B, Shah S, Zuehlsdorff S. Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol. 2011;196:553-561. [PMID: 21343496 DOI: 10.2214/ajr.10.4580] [Cited by in Crossref: 161] [Cited by in F6Publishing: 95] [Article Influence: 16.1] [Reference Citation Analysis]
202 Marra G, Ploussard G, Futterer J, Valerio M; EAU-YAU Prostate Cancer Working Party. Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach? World J Urol 2019;37:277-87. [PMID: 30610359 DOI: 10.1007/s00345-018-02622-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
203 Wang D, Zhang P, Zhang M. Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase. Exp Ther Med 2017;14:5363-70. [PMID: 29285064 DOI: 10.3892/etm.2017.5219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
204 Yang L, Ling W, He D, Lu C, Ma L, Tang L, Luo Y, Chen S. Shear wave-based sound touch elastography in liver fibrosis assessment for patients with autoimmune liver diseases. Quant Imaging Med Surg 2021;11:1532-42. [PMID: 33816189 DOI: 10.21037/qims-20-521] [Reference Citation Analysis]
205 Wu YL, Kumar R, Wang MF, Singh M, Huang JF, Zhu YY, Lin S. Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease. World J Gastroenterol 2021; 27(34): 5753-5763 [PMID: 34629799 DOI: 10.3748/wjg.v27.i34.5753] [Reference Citation Analysis]
206 Nieto J, Dawod E, Deshmukh A, Penn E, Adler D, Saab S. EUS-guided fine-needle core liver biopsy with a modified one-pass, one-actuation wet suction technique comparing two types of EUS core needles. Endosc Int Open 2020;8:E938-43. [PMID: 32617398 DOI: 10.1055/a-1165-1767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
207 Tawada A, Maruyama H, Kamezaki H, Shimada T, Ishibashi H, Takahashi M, Kanda T, Fujiwara K, Imazeki F, Yokosuka O. Magnitude of contrast-enhanced ultrasonography as a noninvasive predictor for hepatic fibrosis: comparison with liver stiffness measurement and serum-based models. Hepatol Int 2013;7:749-57. [PMID: 26201810 DOI: 10.1007/s12072-012-9370-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
208 Merrell MD, Cherrington NJ. Drug metabolism alterations in nonalcoholic fatty liver disease.Drug Metab Rev. 2011;43:317-334. [PMID: 21612324 DOI: 10.3109/03602532.2011.577781] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 10.3] [Reference Citation Analysis]
209 Cheong JY, Um SH, Seo YS, Kim DJ, Hwang SG, Lee YJ, Cho M, Yang JM, Kim YB, Park YN. Non-invasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C. Dig Dis Sci. 2011;56:555-563. [PMID: 20585981 DOI: 10.1007/s10620-010-1305-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
210 Huang J, Shen J, Yang Q, Cheng Z, Chen X, Yu T, Zhong J, Su Y, Guo H, Liang B. Quantification of pancreatic iron overload and fat infiltration and their correlation with glucose disturbance in pediatric thalassemia major patients. Quant Imaging Med Surg 2021;11:665-75. [PMID: 33532266 DOI: 10.21037/qims-20-292] [Reference Citation Analysis]
211 Morishita K, Hiramoto A, Osuga T, Lim SY, Khoirun N, Sasaki N, Nakamura K, Ohta H, Yamasaki M, Takiguchi M. Contrast-enhanced ultrasonography of the hepatic vein in normal dogs. J Vet Med Sci 2017;78:1753-8. [PMID: 27534912 DOI: 10.1292/jvms.16-0062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
212 Watt GP, Lee M, Pan JJ, Fallon MB, Loomba R, Beretta L, McCormick JB, Fisher-Hoch SP. High Prevalence of Hepatic Fibrosis, Measured by Elastography, in a Population-Based Study of Mexican Americans. Clin Gastroenterol Hepatol 2019;17:968-975.e5. [PMID: 29902644 DOI: 10.1016/j.cgh.2018.05.046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
213 Wang HW, Peng CY, Lai HC, Su WP, Lin CH, Chuang PH, Chen SH, Chen CH, Hsu WF, Huang GT. New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis. Sci Rep 2017;7:3259. [PMID: 28607450 DOI: 10.1038/s41598-017-03589-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
214 Gökçe S, Atbinici Z, Aycan Z, Çınar HG, Zorlu P. The Relationship Between Pediatric Nonalcoholic Fatty Liver Disease and Cardiovascular Risk Factors and Increased Risk of Atherosclerosis in Obese Children. Pediatr Cardiol 2013;34:308-15. [DOI: 10.1007/s00246-012-0447-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
215 Xu XY, Kong H, Song RX, Zhai YH, Wu XF, Ai WS, Liu HB. The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy. PLoS One. 2014;9:e100182. [PMID: 24964038 DOI: 10.1371/journal.pone.0100182] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
216 Chalasani N, Toden S, Sninsky JJ, Rava RP, Braun JV, Gawrieh S, Zhuang J, Nerenberg M, Quake SR, Maddala T. Noninvasive stratification of nonalcoholic fatty liver disease by whole transcriptome cell-free mRNA characterization. Am J Physiol Gastrointest Liver Physiol 2021;320:G439-49. [PMID: 33501884 DOI: 10.1152/ajpgi.00397.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
217 Qu Y, Li M, Hamilton G, Zhang YN, Song B. Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis. Eur Radiol 2019;29:5180-9. [PMID: 30877459 DOI: 10.1007/s00330-019-06071-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
218 Pan S, Wang XQ, Guo QY. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging. World J Gastroenterol 2018; 24(18): 2024-2035 [PMID: 29760545 DOI: 10.3748/wjg.v24.i18.2024] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
219 Kim DY, Kim SU, Ahn SH, Park JY, Lee JM, Park YN, Yoon KT, Paik YH, Lee KS, Chon CY, Han KH. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci. 2009;54:1758-1763. [PMID: 19005758 DOI: 10.1007/s10620-008-0541-2] [Cited by in Crossref: 90] [Cited by in F6Publishing: 101] [Article Influence: 6.9] [Reference Citation Analysis]
220 Sekiguchi T, Umemura T, Fujimori N, Shibata S, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E, Ota M. Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis. PLoS One 2015;10:e0131658. [PMID: 26110613 DOI: 10.1371/journal.pone.0131658] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
221 Lee DH, Lee JY, Park MS, Han JK. Non-invasive monitoring of hepatic steatosis via acoustic structure quantification of ultrasonography with MR spectroscopy as the reference standard. Ultrasonography 2020;39:70-8. [PMID: 31639886 DOI: 10.14366/usg.19002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
222 Nakashima M, Sakuragi S, Miyoshi T, Takayama S, Kawaguchi T, Kodera N, Akai H, Koide Y, Otsuka H, Wada T, Kawamoto K, Tanakaya M, Katayama Y, Ito H. Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction. ESC Heart Fail 2021;8:2240-7. [PMID: 33760403 DOI: 10.1002/ehf2.13317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
223 Patel K, Sebastiani G. Limitations of non-invasive tests for assessment of liver fibrosis. JHEP Rep. 2020;2:100067. [PMID: 32118201 DOI: 10.1016/j.jhepr.2020.100067] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 47.0] [Reference Citation Analysis]
224 Chen J, Yin M, Talwalkar JA, Oudry J, Glaser KJ, Smyrk TC, Miette V, Sandrin L, Ehman RL. Diagnostic Performance of MR Elastography and Vibration-controlled Transient Elastography in the Detection of Hepatic Fibrosis in Patients with Severe to Morbid Obesity. Radiology. 2017;283:418-428. [PMID: 27861111 DOI: 10.1148/radiol.2016160685] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 15.8] [Reference Citation Analysis]
225 Shah AR, Al-Hanayneh M, Chowdhry M, Bilal M, Singh S. Endoscopic ultrasound guided liver biopsy for parenchymal liver disease. World J Hepatol 2019; 11(4): 335-343 [PMID: 31114638 DOI: 10.4254/wjh.v11.i4.335] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
226 Cakmakci E, Caliskan KC, Tabakci ON, Tahtabasi M, Karpat Z. Percutaneous liver biopsies guided with ultrasonography: a case series. Iran J Radiol 2013;10:182-4. [PMID: 24348609 DOI: 10.5812/iranjradiol.13184] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
227 Mok SRS, Diehl DL. The Role of EUS in Liver Biopsy. Curr Gastroenterol Rep 2019;21:6. [PMID: 30706151 DOI: 10.1007/s11894-019-0675-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
228 Webster CRL, Center SA, Cullen JM, Penninck DG, Richter KP, Twedt DC, Watson PJ. ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs. J Vet Intern Med 2019;33:1173-200. [PMID: 30844094 DOI: 10.1111/jvim.15467] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
229 Lee S, Kim DY. Non-invasive diagnosis of hepatitis B virus-related cirrhosis. World J Gastroenterol 2014; 20(2): 445-459 [PMID: 24574713 DOI: 10.3748/wjg.v20.i2.445] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
230 Martinez-Urbistondo D, Suarez Del Villar R, Argemí J, Daimiel L, Ramos-López O, San-Cristobal R, Villares P, Martinez JA. Antioxidant Lifestyle, Co-Morbidities and Quality of Life Empowerment Concerning Liver Fibrosis. Antioxidants (Basel) 2020;9:E1125. [PMID: 33202851 DOI: 10.3390/antiox9111125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
231 Yashima Y, Tsujino T, Masuzaki R, Nakai Y, Hirano K, Tateishi R, Sasahira N, Isayama H, Tada M, Yoshida H. Increased liver elasticity in patients with biliary obstruction. J Gastroenterol. 2011;46:86-91. [PMID: 20814804 DOI: 10.1007/s00535-010-0290-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
232 Lee DH, Lee ES, Lee JY, Bae JS, Kim H, Lee KB, Yu SJ, Cho EJ, Lee JH, Cho YY, Han JK, Choi BI. Two-Dimensional-Shear Wave Elastography with a Propagation Map: Prospective Evaluation of Liver Fibrosis Using Histopathology as the Reference Standard. Korean J Radiol 2020;21:1317-25. [PMID: 32729274 DOI: 10.3348/kjr.2019.0978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
233 Chalasani N, Abdelmalek MF, Loomba R, Kowdley KV, McCullough AJ, Dasarathy S, Neuschwander-Tetri BA, Terrault N, Ferguson B, Shringarpure R, Shapiro D, Sanyal AJ. Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis. Liver Int 2019;39:924-32. [PMID: 30253043 DOI: 10.1111/liv.13974] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 14.5] [Reference Citation Analysis]
234 Endo Y, Ohta M, Tada K, Nakanuma H, Saga K, Masuda T, Hirashita T, Iwashita Y, Ozeki Y, Masaki T, Inomata M. Improvement of non-alcoholic fatty liver disease after laparoscopic sleeve gastrectomy in Japanese obese patients. Ann Gastroenterol Surg 2019;3:285-90. [PMID: 31131357 DOI: 10.1002/ags3.12234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
235 Ho MC, Lee YH, Jeng YM, Chen CN, Chang KJ, Tsui PH. Relationship between ultrasound backscattered statistics and the concentration of fatty droplets in livers: an animal study. PLoS One 2013;8:e63543. [PMID: 23704917 DOI: 10.1371/journal.pone.0063543] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
236 Chen B, Schreiber RA, Human DG, Potts JE, Guttman OR. Assessment of Liver Stiffness in Pediatric Fontan Patients Using Transient Elastography. Can J Gastroenterol Hepatol 2016;2016:7125193. [PMID: 27656638 DOI: 10.1155/2016/7125193] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
237 Wang J, Li J, Zhou Q, Zhang D, Bi Q, Wu Y, Huang W. Liver stiffness measurement predicted liver-related events and all-cause mortality: A systematic review and nonlinear dose-response meta-analysis. Hepatol Commun 2018;2:467-76. [PMID: 29619424 DOI: 10.1002/hep4.1154] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
238 Cho HJ, Choi J, Kim B, Ko J, Choi JI, Huh J, Lee JH, Kim JK. Combining hepatic surface nodularity and serum tests better predicts hepatic fibrosis stages in chronic liver disease. Abdom Radiol (NY) 2021;46:4189-99. [PMID: 33977353 DOI: 10.1007/s00261-021-03113-9] [Reference Citation Analysis]
239 Ferraioli G, Tinelli C, Lissandrin R, Zicchetti M, Dal Bello B, Filice G, Filice C. Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis. World J Gastroenterol 2014; 20(21): 6626-6631 [PMID: 24914387 DOI: 10.3748/wjg.v20.i21.6626] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
240 Tamura M, Ohta H, Shimbo G, Osuga T, Sasaki N, Morishita K, Kagawa Y, Takiguchi M. Usefulness of noninvasive shear wave elastography for the assessment of hepatic fibrosis in dogs with hepatic disease. J Vet Intern Med 2019;33:2067-74. [PMID: 31461576 DOI: 10.1111/jvim.15598] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
241 Ricci P, Marigliano C, Cantisani V, Porfiri A, Marcantonio A, Lodise P, D’Ambrosio U, Labbadia G, Maggini E, Mancuso E. Ultrasound evaluation of liver fibrosis: preliminary experience with acoustic structure quantification (ASQ) software. Radiol Med. 2013;118:995-1010. [PMID: 23801388 DOI: 10.1007/s11547-013-0940-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
242 Lim JK, Tate JP, Fultz SL, Goulet JL, Conigliaro J, Bryant KJ, Gordon AJ, Gibert C, Rimland D, Goetz MB, Klein MB, Fiellin DA, Justice AC, Lo Re V 3rd. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. Clin Infect Dis 2014;58:1449-58. [PMID: 24569533 DOI: 10.1093/cid/ciu097] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 7.4] [Reference Citation Analysis]
243 Carter-Kent C, Yerian LM, Brunt EM, Angulo P, Kohli R, Ling SC, Xanthakos SA, Whitington PF, Charatcharoenwitthaya P, Yap J, Lopez R, McCullough AJ, Feldstein AE. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study. Hepatology 2009;50:1113-20. [PMID: 19637190 DOI: 10.1002/hep.23133] [Cited by in Crossref: 134] [Cited by in F6Publishing: 122] [Article Influence: 11.2] [Reference Citation Analysis]
244 Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS; American Association for the Study of Liver Diseases. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54:328-343. [PMID: 21452290 DOI: 10.1002/hep.24330] [Cited by in Crossref: 354] [Cited by in F6Publishing: 255] [Article Influence: 35.4] [Reference Citation Analysis]
245 Liu CH, Liang CC, Huang KW, Liu CJ, Chen SI, Lin JW, Hung PH, Tsai HB, Lai MY, Chen PJ. Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients. Clin J Am Soc Nephrol. 2011;6:1057-1065. [PMID: 21393486 DOI: 10.2215/cjn.04320510] [Cited by in Crossref: 54] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
246 Bae JS, Lee JY, Lee DH, Kim H, Lee Y, Han JK. Quantitative Evaluation of Hepatic Steatosis Using Normalized Local Variance in a Rat Model: Comparison with Histopathology as the Reference Standard. Korean J Radiol 2019;20:1399-407. [PMID: 31464118 DOI: 10.3348/kjr.2019.0068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
247 Liu JY, Lv WJ, Jian JB, Xin XH, Zhao XY, Hu CH. High-resolution three-dimensional visualization of hepatic sinusoids in cirrhotic rats via serial histological sections. Histol Histopathol 2021;36:577-86. [PMID: 33851410 DOI: 10.14670/HH-18-339] [Reference Citation Analysis]
248 Brescini L, Orsetti E, Gesuita R, Piraccini F, Marchionni E, Staffolani S, Castelli P, Drenaggi D, Barchiesi F. Evaluating Liver Fibrosis by Transient Elastometry in Patients With HIV-HCV Coinfection and Monoinfection. Hepat Mon 2014;14:e15426. [PMID: 25337140 DOI: 10.5812/hepatmon.15426] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
249 Loria P, Lonardo A, Leonardi F, Fontana C, Carulli L, Verrone AM, Borsatti A, Bertolotti M, Cassani F, Bagni A. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci. 2003;48:2173-2181. [PMID: 14705824 DOI: 10.1023/b:ddas.0000004522.36120.08] [Cited by in Crossref: 91] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
250 Moon HW, Park M, Hur M, Kim H, Choe WH, Yun YM. Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases. Ann Lab Med 2018;38:331-7. [PMID: 29611383 DOI: 10.3343/alm.2018.38.4.331] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
251 Sirlin CB, Reeder SB. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am. 2010;18:359-381, ix. [PMID: 21094445 DOI: 10.1016/j.mric.2010.08.014] [Cited by in Crossref: 107] [Cited by in F6Publishing: 98] [Article Influence: 10.7] [Reference Citation Analysis]
252 Qiu T, Wang H, Song J, Ling W, Shi Y, Guo G, Luo Y. Assessment of liver fibrosis by ultrasound elastography and contrast-enhanced ultrasound: a randomized prospective animal study. Exp Anim 2018;67:117-26. [PMID: 29081454 DOI: 10.1538/expanim.17-0098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
253 Hamesch K, Strnad P. Non-Invasive Assessment and Management of Liver Involvement in Adults With Alpha-1 Antitrypsin Deficiency. Chronic Obstr Pulm Dis 2020;7:260-71. [PMID: 32697896 DOI: 10.15326/jcopdf.7.3.2019.0161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
254 Yang X, Chang X, Wu S, Sun X, Zhu X, Wang L, Xu Y, Yao X, Rao S, Hu X, Xia M, Bian H, Yan H, Gao X. Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease. Lipids Health Dis 2021;20:27. [PMID: 33757528 DOI: 10.1186/s12944-021-01453-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
255 Righi S, Fiorini E, De Molo C, Cipriano V, Cassani F, Muratori L, Lenzi M, Morselli Labate AM, Serra C. ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study. J Ultrasound. 2012;15:226-231. [PMID: 23730386 DOI: 10.1016/j.jus.2012.10.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
256 Price JC, Seaberg EC, Badri S, Witt MD, D'Acunto K, Thio CL. HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis 2012;205:1005-13. [PMID: 22291196 DOI: 10.1093/infdis/jir885] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 5.3] [Reference Citation Analysis]
257 Sumida Y, Eguchi Y, Ono M. Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan. World J Hepatol 2010; 2(10): 374-383 [PMID: 21160946 DOI: 10.4254/wjh.v2.i10.374] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
258 Kanki A, Maeba K, Sotozono H, Yasokawa K, Higaki A, Yamamoto A, Tamada T. Evaluation of liver fibrosis using hepatic extracellular volume fraction by contrast-enhanced computed tomography before and after direct-acting antiviral therapy in patients with chronic hepatitis C infection: comparison with serological liver fibrosis markers. Br J Radiol 2021;94:20210045. [PMID: 34586878 DOI: 10.1259/bjr.20210045] [Reference Citation Analysis]
259 Ozaki K, Matsui O, Kobayashi S, Minami T, Kitao A, Gabata T. Morphometric changes in liver cirrhosis: aetiological differences correlated with progression. Br J Radiol. 2016;89:20150896. [PMID: 26765832 DOI: 10.1259/bjr.20150896] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
260 Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol 2015; 7(11): 1450-1459 [PMID: 26085906 DOI: 10.4254/wjh.v7.i11.1450] [Cited by in Crossref: 116] [Cited by in F6Publishing: 98] [Article Influence: 19.3] [Reference Citation Analysis]
261 Wang X, Xie G, Wang X, Zhou M, Yu H, Lin Y, Du G, Luo G, Liu P. Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients. Evid Based Complement Alternat Med 2015;2015:464969. [PMID: 25667596 DOI: 10.1155/2015/464969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
262 Tarantino G, Spanò A, Loi G, Parisi A, Tarantino M, Brancaccio G, Gaeta GB, Riccio A. Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis? World J Gastroenterol 2011; 17(12): 1606-1613 [PMID: 21472128 DOI: 10.3748/wjg.v17.i12.1606] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
263 Park MS, Kim SW, Yoon KT, Kim SU, Park SY, Tak WY, Kweon YO, Cho M, Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Factors Influencing the Diagnostic Accuracy of Acoustic Radiation Force Impulse Elastography in Patients with Chronic Hepatitis B. Gut Liver. 2016;10:275-282. [PMID: 26087790 DOI: 10.5009/gnl14391] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
264 Sulkowski MS. Hepatitis C virus infection in HIV-infected patients. Curr HIV/AIDS Rep 2004;1:128-35. [PMID: 16091233 DOI: 10.1007/s11904-004-0019-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
265 Verdelho Machado M. Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance? GE Port J Gastroenterol 2017;24:157-60. [PMID: 29255744 DOI: 10.1159/000478944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
266 El-Shabrawi MH, El-Karaksy HM, Okahsa SH, Kamal NM, El-Batran G, Badr KA. Outpatient blind percutaneous liver biopsy in infants and children: is it safe? Saudi J Gastroenterol 2012;18:26-33. [PMID: 22249089 DOI: 10.4103/1319-3767.91735] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
267 Zhao H, Chen J, Meixner DD, Xie H, Shamdasani V, Zhou S, Robert JL, Urban MW, Sanchez W, Callstrom MR, Ehman RL, Greenleaf JF, Chen S. Noninvasive assessment of liver fibrosis using ultrasound-based shear wave measurement and comparison to magnetic resonance elastography. J Ultrasound Med 2014;33:1597-604. [PMID: 25154941 DOI: 10.7863/ultra.33.9.1597] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
268 Venkatesh SK, Yin M, Takahashi N, Glockner JF, Talwalkar JA, Ehman RL. Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography. Abdom Imaging. 2015;40:766-775. [PMID: 25805619 DOI: 10.1007/s00261-015-0347-6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 9.5] [Reference Citation Analysis]
269 Allen AM, Shah VH, Therneau TM, Venkatesh SK, Mounajjed T, Larson JJ, Mara KC, Schulte PJ, Kellogg TA, Kendrick ML, McKenzie TJ, Greiner SM, Li J, Glaser KJ, Wells ML, Chen J, Ehman RL, Yin M. The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery. Hepatology 2020;71:510-21. [PMID: 30582669 DOI: 10.1002/hep.30483] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 10.5] [Reference Citation Analysis]
270 van Welzen BJ, Mudrikova T, El Idrissi A, Hoepelman AIM, Arends JE. A review of Non-Alcoholic Fatty Liver Disease in HIV-infected patients: The next big thing? Infect Dis Ther. 2019;8:33-50. [PMID: 30607807 DOI: 10.1007/s40121-018-0229-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
271 Towbin AJ, Roth CJ, Petersilge CA, Garriott K, Buckwalter KA, Clunie DA. The Importance of Body Part Labeling to Enable Enterprise Imaging: A HIMSS-SIIM Enterprise Imaging Community Collaborative White Paper. J Digit Imaging 2021;34:1-15. [PMID: 33481143 DOI: 10.1007/s10278-020-00415-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
272 Bourvis N, Boelle PY, Cesbron JY, Valleron AJ. Risk assessment of transmission of sporadic Creutzfeldt-Jakob disease in endodontic practice in absence of adequate prion inactivation. PLoS One 2007;2:e1330. [PMID: 18159228 DOI: 10.1371/journal.pone.0001330] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
273 Caussy C, Reeder SB, Sirlin CB, Loomba R. Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials. Hepatology 2018;68:763-72. [PMID: 29356032 DOI: 10.1002/hep.29797] [Cited by in Crossref: 112] [Cited by in F6Publishing: 101] [Article Influence: 56.0] [Reference Citation Analysis]
274 Flemming JA, Hurlbut DJ, Mussari B, Hookey LC. Liver biopsies for chronic hepatitis C: should nonultrasound-guided biopsies be abandoned? Can J Gastroenterol 2009;23:425-30. [PMID: 19543573 DOI: 10.1155/2009/370651] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
275 Sönmez S, Boşat M, Yurtseven N, Yurtseven E. The role of elastography in the assessment of chronic liver disease in children. Afr Health Sci 2019;19:2806-11. [PMID: 32127854 DOI: 10.4314/ahs.v19i3.57] [Reference Citation Analysis]
276 Sack I, Fischer T, Thomas A, Braun J. [Magnetic resonance elastography of the liver]. Radiologe 2012;52:738-44. [PMID: 22777306 DOI: 10.1007/s00117-012-2311-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
277 Baba M, Furuya K, Bandou H, Kasai K, Sadaoka K. Discrimination of individuals in a general population at high-risk for alcoholic and non-alcoholic fatty liver disease based on liver stiffness: a cross section study. BMC Gastroenterol. 2011;11:70. [PMID: 21669003 DOI: 10.1186/1471-230x-11-70] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
278 Kim MY, Jeong WK, Baik SK. Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol 2014; 20(15): 4300-4315 [PMID: 24764667 DOI: 10.3748/wjg.v20.i15.4300] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 58] [Article Influence: 9.3] [Reference Citation Analysis]
279 Bruno C, Minniti S, Bucci A, Pozzi Mucelli R. ARFI: from basic principles to clinical applications in diffuse chronic disease-a review. Insights Imaging 2016;7:735-46. [PMID: 27553006 DOI: 10.1007/s13244-016-0514-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
280 Sporea I, Popescu A, Sirli R. Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol 2008; 14(21): 3396-3402 [PMID: 18528937 DOI: 10.3748/wjg.14.3396] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
281 Gomaa AI, Khan SA, Leen EL, Waked I, Taylor-Robinson SD. Diagnosis of hepatocellular carcinoma. World J Gastroenterol 2009; 15(11): 1301-1314 [PMID: 19294759 DOI: 10.3748/wjg.15.1301] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 87] [Article Influence: 8.7] [Reference Citation Analysis]
282 Dioguardi N, Grizzi F, Fiamengo B, Russo C. Metrically measuring liver biopsy: A chronic hepatitis B and C computer-aided morphologic description. World J Gastroenterol 2008; 14(48): 7335-7344 [PMID: 19109867 DOI: 10.3748/wjg.14.7335] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
283 Chen S, Sanchez W, Callstrom MR, Gorman B, Lewis JT, Sanderson SO, Greenleaf JF, Xie H, Shi Y, Pashley M. Assessment of liver viscoelasticity by using shear waves induced by ultrasound radiation force. Radiology. 2013;266:964-970. [PMID: 23220900 DOI: 10.1148/radiol.12120837] [Cited by in Crossref: 147] [Cited by in F6Publishing: 104] [Article Influence: 16.3] [Reference Citation Analysis]
284 Coral GP, Antunes AD, Serafini AP, Araujo FB, Mattos AA. LIVER BIOPSY: IMPORTANCE OF SPECIMEN SIZE IN THE DIAGNOSIS AND STAGING OF CHRONIC VIRAL HEPATITIS. Rev Inst Med Trop Sao Paulo 2016;58:10. [PMID: 26910447 DOI: 10.1590/S1678-9946201658010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
285 Yu JS, Shim JH, Chung JJ, Kim JH, Kim KW. Double contrast-enhanced MRI of viral hepatitis-induced cirrhosis: correlation of gross morphological signs with hepatic fibrosis. Br J Radiol. 2010;83:212-217. [PMID: 19505965 DOI: 10.1259/bjr/70974553] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
286 Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, Eisele S, Stickel F, Longerich T, Schirmacher P, Seitz HK. Increased liver stiffness in alcoholic liver disease: Differentiating fibrosis from steatohepatitis. World J Gastroenterol 2010; 16(8): 966-972 [PMID: 20180235 DOI: 10.3748/wjg.v16.i8.966] [Cited by in CrossRef: 141] [Cited by in F6Publishing: 116] [Article Influence: 12.8] [Reference Citation Analysis]
287 Campos-Murguía A, Ruiz-Margáin A, González-Regueiro JA, Macías-Rodríguez RU. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(39): 5919-5943 [PMID: 33132645 DOI: 10.3748/wjg.v26.i39.5919] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
288 Mouralidarane A, Lin CI, Suleyman N, Soeda J, Oben JA. Practical management of the increasing burden of non-alcoholic fatty liver disease. Frontline Gastroenterol 2010;1:149-55. [PMID: 28839568 DOI: 10.1136/fg.2009.000935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
289 Kühn JP, Hernando D, Muñoz del Rio A, Evert M, Kannengiesser S, Völzke H, Mensel B, Puls R, Hosten N, Reeder SB. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 2012;265:133-42. [PMID: 22923718 DOI: 10.1148/radiol.12112520] [Cited by in Crossref: 121] [Cited by in F6Publishing: 119] [Article Influence: 13.4] [Reference Citation Analysis]
290 Sanai FM, Farah T, Albeladi K, Batwa F, Dahlan Y, Babatin MA, Al-Ashgar H, AlMana H, Alsaad KS, AlSwat K, Aljumah A, AlTraif IH, Kailani BE, Bzeizi KI. Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B. BMC Gastroenterol 2017;17:101. [PMID: 28841822 DOI: 10.1186/s12876-017-0658-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
291 Zou X, Chi X, Pan Y, Du D, Sun H, Matsuda A, Li W, Kuno A, Zhang X, Narimatsu H, Niu J, Zhang Y. LecT-Hepa facilitates estimating treatment outcome during interferon therapy in chronic hepatitis C patients. Clin Proteomics 2014;11:44. [PMID: 25593566 DOI: 10.1186/1559-0275-11-44] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
292 Kim MJ, Park HS, Yhim HY. Intravascular large b-cell lymphoma diagnosed via transjugular liver biopsy in a patient with liver dysfunction and thrombocytopenia: A Case Report. Medicine (Baltimore) 2017;96:e6925. [PMID: 28489811 DOI: 10.1097/MD.0000000000006925] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
293 Chrostek L, Przekop D, Gruszewska E, Gudowska-Sawczuk M, Cylwik B. Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics. Biomed Res Int 2019;2019:3646975. [PMID: 31192254 DOI: 10.1155/2019/3646975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
294 Fujita N, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Shirabe K, Yoshizumi T, Kotoh K, Furusyo N, Hida T, Oda Y, Fujioka T, Honda H. Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry. World J Gastroenterol 2016; 22(40): 8949-8955 [PMID: 27833386 DOI: 10.3748/wjg.v22.i40.8949] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
295 Shen Y, Shi G, Huang C, Zhu X, Chen S, Sun H, Zhou J, Fan J. Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma. PLoS One 2015;10:e0140932. [PMID: 26501145 DOI: 10.1371/journal.pone.0140932] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
296 Yao TT, Pan J, Qian JD, Cheng H, Wang Y, Wang GQ. Shear wave elastography may be sensitive and more precise than transient elastography in predicting significant fibrosis. World J Clin Cases 2020; 8(17): 3730-3742 [PMID: 32953849 DOI: 10.12998/wjcc.v8.i17.3730] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
297 Dichtel LE, Eajazi A, Miller KK, Torriani M, Bredella MA. Short- and Long-Term Reproducibility of Intrahepatic Lipid Quantification by 1H-MR Spectroscopy and CT in Obesity. J Comput Assist Tomogr 2016;40:678-82. [PMID: 27116479 DOI: 10.1097/RCT.0000000000000423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
298 Toshima T, Shirabe K, Ikegami T, Yoshizumi T, Kuno A, Togayachi A, Gotoh M, Narimatsu H, Korenaga M, Mizokami M, Nishie A, Aishima S, Maehara Y. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis. J Gastroenterol. 2015;50:76-84. [PMID: 24603981 DOI: 10.1007/s00535-014-0946-y] [Cited by in Crossref: 113] [Cited by in F6Publishing: 109] [Article Influence: 16.1] [Reference Citation Analysis]
299 Krishna M. Role of special stains in diagnostic liver pathology. Clin Liver Dis (Hoboken) 2013;2:S8-S10. [PMID: 30992876 DOI: 10.1002/cld.148] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
300 Yeom SK, Lee CH, Cha SH, Park CM. Prediction of liver cirrhosis, using diagnostic imaging tools. World J Hepatol 2015; 7(17): 2069-2079 [PMID: 26301049 DOI: 10.4254/wjh.v7.i17.2069] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
301 Yang YL, Di L, Duan YY, Liu X, Liu J, Yang RJ, Chen S, Yuan LJ. A prospective experimental study of liver fibrosis with ultrasound and its correlation with hepatic reserve function and hemodynamics. BMC Gastroenterol. 2012;12:168. [PMID: 23173929 DOI: 10.1186/1471-230X-12-168] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
302 Grizzi F, Russo C, Franceschini B, Rocco MD, Torri V, Morenghi E, Fassati LR, Dioguardi N. Sampling variability of computer-aided fractal-corrected measures of liver fibrosis in needle biopsy specimens. World J Gastroenterol 2006; 12(47): 7660-7665 [PMID: 17171796 DOI: 10.3748/wjg.v12.i47.7660] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
303 Hassan S, Syed S, Kehar SI. Glial Fibrillary Acidic Protein (GFAP) as a Mesenchymal marker of Early Hepatic Stellate Cells Activation in Liver Fibrosis in Chronic Hepatitis C Infection. Pak J Med Sci 2014;30:1027-32. [PMID: 25225520 DOI: 10.12669/pjms.305.5534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
304 Heo JY, Kim BK, Park JY, Kim DY, Ahn SH, Kim HS, Park YN, Han KH, Song K, Kim SU. Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B. Gut Liver 2018;12:190-200. [PMID: 29069887 DOI: 10.5009/gnl17092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
305 Ebrahimi H, Naderian M, Sohrabpour AA. New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article. Middle East J Dig Dis. 2016;8:166-178. [PMID: 27698966 DOI: 10.15171/mejdd.2016.29] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
306 Guzmán Aroca F, Ayala I, Serrano L, Berná-Serna JD, Castell MT, García-Pérez B, Reus M. Assessment of liver steatosis in chicken by using acoustic radiation force impulse imaging: preliminary results. Eur Radiol 2010;20:2367-71. [PMID: 20445981 DOI: 10.1007/s00330-010-1808-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
307 Corbin IR, Minuk GY. Serial percutaneous liver biopsies in laboratory rats. Dig Dis Sci 2003;48:1939-43. [PMID: 14627337 DOI: 10.1023/a:1026228018643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
308 Dhyani M, Anvari A, Samir AE. Ultrasound elastography: liver. Abdom Imaging 2015;40:698-708. [PMID: 25690689 DOI: 10.1007/s00261-015-0373-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
309 Li K, Qin L, Jiang S, Li A, Zhang C, Liu G, Sun J, Sun H, Zhao Y, Li N, Zhang Y. The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylation. Clin Epigenetics 2020;12:81. [PMID: 32513305 DOI: 10.1186/s13148-020-00847-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
310 Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006;55:569-78. [PMID: 16531536 DOI: 10.1136/gut.2005.084475] [Cited by in Crossref: 275] [Cited by in F6Publishing: 246] [Article Influence: 18.3] [Reference Citation Analysis]
311 Giunta M, Conte D, Fraquelli M. Role of spleen elastography in patients with chronic liver diseases. World J Gastroenterol 2016; 22(35): 7857-7867 [PMID: 27672283 DOI: 10.3748/wjg.v22.i35.7857] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
312 Sawh MC, Newton KP, Goyal NP, Angeles JE, Harlow K, Bross C, Schlein AN, Hooker JC, Sy EZ, Glaser KJ, Yin M, Ehman RL, Sirlin CB, Schwimmer JB. Normal range for MR elastography measured liver stiffness in children without liver disease. J Magn Reson Imaging 2020;51:919-27. [PMID: 31452280 DOI: 10.1002/jmri.26905] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
313 Patel M, Tann M, Liangpunsakul S. CT-scan Based Liver and Spleen Volume Measurement as a Prognostic Indicator for Patients with Cirrhosis. Am J Med Sci 2020:S0002-9629(20)30485-7. [PMID: 33947583 DOI: 10.1016/j.amjms.2020.10.031] [Reference Citation Analysis]
314 Inoue Y, Kokudo N. Elastography for hepato-biliary-pancreatic surgery. Surg Today. 2014;44:1793-1800. [PMID: 24292652 DOI: 10.1007/s00595-013-0799-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
315 Amarapurkar D, Amarapurkar A. Indications of Liver Biopsy in the Era of Noninvasive Assessment of Liver Fibrosis. J Clin Exp Hepatol 2015;5:314-9. [PMID: 26900273 DOI: 10.1016/j.jceh.2015.08.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
316 Ding Z, Lin K, Fu J, Huang Q, Fang G, Tang Y, You W, Lin Z, Lin Z, Pan X, Zeng Y. An MR-based radiomics model for differentiation between hepatocellular carcinoma and focal nodular hyperplasia in non-cirrhotic liver. World J Surg Oncol 2021;19:181. [PMID: 34154624 DOI: 10.1186/s12957-021-02266-7] [Reference Citation Analysis]
317 罗子华, 邹健, 宓林, 刘燕, 童依丽, 于晓峰. Fibroscan评价慢性病毒性肝炎肝纤维化(≥F2)的Meta分析. 世界华人消化杂志 2013; 21(33): 3724-3735 [DOI: 10.11569/wcjd.v21.i33.3724] [Reference Citation Analysis]
318 Kuroda H, Kakisaka K, Kamiyama N, Oikawa T, Onodera M, Sawara K, Oikawa K, Endo R, Takikawa Y, Suzuki K. Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude. World J Gastroenterol 2012; 18(29): 3889-3895 [PMID: 22876042 DOI: 10.3748/wjg.v18.i29.3889] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
319 Anania G, Gigante E, Piciucchi M, Pilozzi E, Pucci E, Pellicelli AM, Capotondi C, Rossi M, Baccini F, Antonelli G, Begini P, Fave GD, Marignani M. Liver biopsy: Analysis of results of two specialist teams. World J Gastrointest Pathophysiol 2014; 5(2): 114-119 [PMID: 24891983 DOI: 10.4291/wjgp.v5.i2.114] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
320 Lee HS, Kim JK, Cheong JY, Han EJ, An SY, Song JH, Jung YJ, Jeon SC, Jung MW, Jang EJ. Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis. Korean J Hepatol. 2010;16:369-375. [PMID: 21415580 DOI: 10.3350/kjhep.2010.16.4.369] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
321 Mitsuka Y, Midorikawa Y, Abe H, Matsumoto N, Moriyama M, Haradome H, Sugitani M, Tsuji S, Takayama T. A prediction model for the grade of liver fibrosis using magnetic resonance elastography. BMC Gastroenterol 2017;17:133. [PMID: 29179678 DOI: 10.1186/s12876-017-0700-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
322 Zhang L, Li QY, Duan YY, Yan GZ, Yang YL, Yang RJ. Artificial neural network aided non-invasive grading evaluation of hepatic fibrosis by duplex ultrasonography. BMC Med Inform Decis Mak 2012;12:55. [PMID: 22716936 DOI: 10.1186/1472-6947-12-55] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
323 Roh YH, Kang BK, Jun DW, Lee CM, Kim M. Role of FIB-4 for reassessment of hepatic fibrosis burden in referral center. Sci Rep 2021;11:13616. [PMID: 34193951 DOI: 10.1038/s41598-021-93038-6] [Reference Citation Analysis]
324 Kosmalski M, Mokros Ł, Kuna P, Witusik A, Pietras T. Changes in the immune system - the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease. Cent Eur J Immunol 2018;43:231-9. [PMID: 30135638 DOI: 10.5114/ceji.2018.77395] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
325 Dugum MF, McCullough AJ. Acute Alcoholic Hepatitis, the Clinical Aspects. Clin Liver Dis 2016;20:499-508. [PMID: 27373612 DOI: 10.1016/j.cld.2016.02.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
326 Kim KY, Song JS, Kannengiesser S, Han YM. Hepatic fat quantification using the proton density fat fraction (PDFF): utility of free-drawn-PDFF with a large coverage area. Radiol Med 2015;120:1083-93. [PMID: 25952293 DOI: 10.1007/s11547-015-0545-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
327 Reece J, Pavlick M, Penninck DG, Webster CRL. Hemorrhage and complications associated with percutaneous ultrasound guided liver biopsy in dogs. J Vet Intern Med 2020;34:2398-404. [PMID: 33125175 DOI: 10.1111/jvim.15942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
328 Mehta SH, Buckle GC. Assessment of liver disease (noninvasive methods). Curr Opin HIV AIDS 2011;6:465-71. [PMID: 21857222 DOI: 10.1097/COH.0b013e32834b55c7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
329 Wahl K, Rosenberg W, Vaske B, Manns MP, Schulze-Osthoff K, Bahr MJ, Bantel H. Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastography. PLoS One 2012;7:e51906. [PMID: 23284811 DOI: 10.1371/journal.pone.0051906] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
330 Rudolph B, Selig T, Li Y, Ovchinsky N, Kogan-Liberman D, Liszewski MC, Levin T, Ewart M, Liu Q, Viswanathan S, Lin J, Xue X, Burk RD, Strickler HD. Relationship of Vitamin D Deficiency and Fatty Liver in Children as Defined by Multiple Imaging and Histologic Endpoints. JPGN Rep 2021;2:e077. [PMID: 34723254 DOI: 10.1097/PG9.0000000000000077] [Reference Citation Analysis]
331 Chen SZ, Yuan J, Deng M, Wei J, Zhou J, Wáng YX. Chemical exchange saturation transfer (CEST) MR technique for in-vivo liver imaging at 3.0 tesla. Eur Radiol 2016;26:1792-800. [PMID: 26334509 DOI: 10.1007/s00330-015-3972-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
332 Wadhva RK, Haque MM, Luck NH, Tasneem AA, Abbas Z, Mubarak M. Diagnostic Accuracy of Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis 4 Scores in Predicting Advanced Liver Fibrosis in Patients with End-stage Renal Disease and Chronic Viral Hepatitis: Experience from Pakistan. J Transl Int Med 2018;6:38-42. [PMID: 29607303 DOI: 10.2478/jtim-2018-0008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
333 Chon YE, Choi EH, Song KJ, Park JY, Kim DY, Han KH, Chon CY, Ahn SH, Kim SU. Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis. PLoS One. 2012;7:e44930. [PMID: 23049764 DOI: 10.1371/journal.pone.0044930] [Cited by in Crossref: 179] [Cited by in F6Publishing: 172] [Article Influence: 19.9] [Reference Citation Analysis]
334 Noguchi R, Kaji K, Namisaki T, Moriya K, Kitade M, Takeda K, Kawaratani H, Okura Y, Aihara Y, Furukawa M, Mitoro A, Yoshiji H. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B. World J Gastroenterol 2017; 23(36): 6705-6714 [PMID: 29085215 DOI: 10.3748/wjg.v23.i36.6705] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
335 Jeong JY, Kim TY, Sohn JH, Kim Y, Jeong WK, Oh YH, Yoo KS. Real time shear wave elastography in chronic liver diseases: Accuracy for predicting liver fibrosis, in comparison with serum markers. World J Gastroenterol 2014; 20(38): 13920-13929 [PMID: 25320528 DOI: 10.3748/wjg.v20.i38.13920] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
336 Takeda T, Yasuda T, Nakayama Y, Nakaya M, Kimura M, Yamashita M, Sawada A, Abo K, Takeda S, Sakaguchi H, Shiomi S, Asai H, Seki S. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J Gastroenterol 2006; 12(48): 7768-7773 [PMID: 17203518 DOI: 10.3748/wjg.v12.i48.7768] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
337 Goto Y, Okuda K, Akasu G, Kinoshita H, Tanaka H. Noninvasive diagnosis of compensated cirrhosis using an analysis of the time-intensity curve portal vein slope gradient on contrast-enhanced ultrasonography. Surg Today 2014;44:1496-505. [PMID: 24136649 DOI: 10.1007/s00595-013-0750-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
338 Glińska-Suchocka K, Jankowski M, Kubiak K, Spużak J, Borusewicz P, Kubiak-Nowak D. A liver core needle biopsy technique in guinea pigs (Cavia porcellus). Acta Vet Scand 2019;61:27. [PMID: 31196125 DOI: 10.1186/s13028-019-0462-4] [Reference Citation Analysis]
339 Ragazzo TG, Paranagua-Vezozzo D, Lima FR, de Campos Mazo DF, Pessoa MG, Oliveira CP, Alves VAF, Carrilho FJ. Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C. Clinics (Sao Paulo) 2017;72:516-25. [PMID: 29069254 DOI: 10.6061/clinics/2017(09)01] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
340 Yin M, Chen J, Glaser KJ, Talwalkar JA, Ehman RL. Abdominal magnetic resonance elastography. Top Magn Reson Imaging. 2009;20:79-87. [PMID: 20010062 DOI: 10.1097/rmr.0b013e3181c4737e] [Cited by in Crossref: 61] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
341 Maklad S, Esmat G, Hassan E, Attalah M, Zeid AA. Liver Biopsy and FibroScan to Detect Early Histopathological Changes in Chronic HBV Patients Not Candidate for Treatment. Gastroenterology Res 2014;7:56-63. [PMID: 27785271 DOI: 10.14740/gr597w] [Reference Citation Analysis]
342 Johnson KD, Laoveeravat P, Yee EU, Perisetti A, Thandassery RB, Tharian B. Endoscopic ultrasound guided liver biopsy: Recent evidence. World J Gastrointest Endosc 2020; 12(3): 83-97 [PMID: 32218888 DOI: 10.4253/wjge.v12.i3.83] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
343 Bannas P, Kramer H, Hernando D, Agni R, Cunningham AM, Mandal R, Motosugi U, Sharma SD, Munoz del Rio A, Fernandez L, Reeder SB. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers. Hepatology. 2015;62:1444-1455. [PMID: 26224591 DOI: 10.1002/hep.28012] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 13.2] [Reference Citation Analysis]
344 Maev IV, Samsonov AA, Palgova LK, Pavlov CS, Vovk EI, Shirokova EN, Starostin KM. Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study). BMJ Open Gastroenterol 2020;7:e000341. [PMID: 32095253 DOI: 10.1136/bmjgast-2019-000341] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
345 Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, Gamst AC, Middleton M, Brunt EM, Loomba R, Lavine JE, Schwimmer JB, Sirlin CB. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013;267:422-431. [PMID: 23382291 DOI: 10.1148/radiol.12120896] [Cited by in Crossref: 259] [Cited by in F6Publishing: 247] [Article Influence: 32.4] [Reference Citation Analysis]
346 Osman AM, El Shimy A, Abd El Aziz MM. 2D shear wave elastography (SWE) performance versus vibration-controlled transient elastography (VCTE/fibroscan) in the assessment of liver stiffness in chronic hepatitis. Insights Imaging 2020;11:38. [PMID: 32152802 DOI: 10.1186/s13244-020-0839-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
347 Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol. 2015;7:1450-1459. [PMID: 26085906 DOI: 10.4254/wjh.v7.i11] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
348 Sagir A, Ney D, Oh J, Pandey S, Kircheis G, Mayatepek E, Häussinger D. Evaluation of Acoustic Radiation Force Impulse Imaging (ARFI) for the Determination of Liver Stiffness Using Transient Elastography as a Reference in Children. Ultrasound Int Open 2015;1:E2-7. [PMID: 27689145 DOI: 10.1055/s-0035-1554659] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
349 Zeng J, Huang ZP, Zheng J, Wu T, Zheng RQ. Non-invasive assessment of liver fibrosis using two-dimensional shear wave elastography in patients with autoimmune liver diseases. World J Gastroenterol 2017; 23(26): 4839-4846 [PMID: 28765706 DOI: 10.3748/wjg.v23.i26.4839] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
350 Nan Y, Niu X, Wang R, Zhao S, Fu N, Du J, Wang Y, Wang B, Zhang Y. microRNA-1273g-3p is a useful non-invasive test for the prediction of liver fibrosis in patients with chronic hepatitis C. Exp Ther Med 2019;17:1817-24. [PMID: 30783454 DOI: 10.3892/etm.2018.7114] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
351 Saito M, Yano Y, Hirano H, Momose K, Yoshida M, Azuma T. Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C. Hepat Mon 2015;15:e22978. [PMID: 25788955 DOI: 10.5812/hepatmon.22978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
352 Zhang YN, Fowler KJ, Ozturk A, Potu CK, Louie AL, Montes V, Henderson WC, Wang K, Andre MP, Samir AE, Sirlin CB. Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography. J Magn Reson Imaging 2020;51:25-42. [PMID: 30859677 DOI: 10.1002/jmri.26716] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
353 Lu PX, Huang H, Yuan J, Zhao F, Chen ZY, Zhang Q, Ahuja AT, Zhou BP, Wáng YX. Decreases in molecular diffusion, perfusion fraction and perfusion-related diffusion in fibrotic livers: a prospective clinical intravoxel incoherent motion MR imaging study. P. LoS One. 2014;9:e113846. [PMID: 25436458 DOI: 10.1371/journal.pone.0113846] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
354 Lombardi R, Buzzetti E, Roccarina D, Tsochatzis EA. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. World J Gastroenterol 2015; 21(39): 11044-11052 [PMID: 26494961 DOI: 10.3748/wjg.v21.i39.11044] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
355 Segovia-Silvestre T, Reichenbach V, Fernández-Varo G, Vassiliadis E, Barascuk N, Morales-Ruiz M, Karsdal MA, Jiménez W. Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis. Fibrogenesis Tissue Repair 2011;4:19. [PMID: 21813019 DOI: 10.1186/1755-1536-4-19] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
356 Motola DL, Caravan P, Chung RT, Fuchs BC. Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions. Curr Pathobiol Rep 2014;2:245-56. [PMID: 25396099 DOI: 10.1007/s40139-014-0061-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
357 Lin YH, Liao YY, Yeh CK, Yang KC, Tsui PH. Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome. Entropy (Basel) 2018;20:E893. [PMID: 33266617 DOI: 10.3390/e20120893] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
358 Kang BK, Kim M, Song SY, Jun DW, Jang K. Feasibility of modified Dixon MRI techniques for hepatic fat quantification in hepatic disorders: validation with MRS and histology. Br J Radiol 2018;91:20170378. [PMID: 29022777 DOI: 10.1259/bjr.20170378] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
359 Wang B, Sun Y, Zhou J, Wu X, Chen S, Shi Y, Wu S, Liu H, Ren Y, Ou X, Jia J, You H. SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies. Hepatol Int 2019;13:501-9. [PMID: 31187402 DOI: 10.1007/s12072-019-09955-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
360 Verloh N, Utpatel K, Haimerl M, Zeman F, Fellner C, Dahlke M, Renner P, Seyfried T, Müller M, Stroszczynski C, Evert M, Wiggermann P. DWI - histology: a possible means of determining degree of liver fibrosis? Oncotarget 2018;9:20112-8. [PMID: 29732007 DOI: 10.18632/oncotarget.24981] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
361 Syn WK, Bruckner-Holt C, Farmer A, Howdle S, Bateman J. Liver biopsy in a district general hospital: Changes over two decades. World J Gastroenterol 2007; 13(40): 5336-5342 [PMID: 17879403 DOI: 10.3748/wjg.v13.i40.5336] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
362 Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, Bettencourt R, Changchien C, Brenner DA, Sirlin C. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology. 2013;58:1930-1940. [PMID: 23696515 DOI: 10.1002/hep.26455] [Cited by in Crossref: 286] [Cited by in F6Publishing: 257] [Article Influence: 35.8] [Reference Citation Analysis]
363 Ferraioli G, Tinelli C, Dal Bello B, Zicchetti M, Lissandrin R, Filice G, Filice C, Above E, Barbarini G, Brunetti E, Calderon W, Di Gregorio M, Gulminetti R, Lanzarini P, Ludovisi S, Maiocchi L, Malfitano A, Michelone G, Minoli L, Mondelli M, Novati S, Patruno SF, Perretti A, Poma G, Sacchi P, Zanaboni D, Zaramella M. Performance of liver stiffness measurements by transient elastography in chronic hepatitis. World J Gastroenterol 2013; 19(1): 49-56 [PMID: 23326162 DOI: 10.3748/wjg.v19.i1.49] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
364 Pu K, Wang Y, Bai S, Wei H, Zhou Y, Fan J, Qiao L. Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis. BMC Gastroenterol 2019;19:51. [PMID: 30961539 DOI: 10.1186/s12876-019-0961-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 24.0] [Reference Citation Analysis]
365 Colombo S, Buonocore M, Del Poggio A, Jamoletti C, Elia S, Mattiello M, Zabbialini D, Del Poggio P. Head-to-head comparison of transient elastography (TE), real-time tissue elastography (RTE), and acoustic radiation force impulse (ARFI) imaging in the diagnosis of liver fibrosis. J Gastroenterol. 2012;47:461-469. [PMID: 22223175 DOI: 10.1007/s00535-011-0509-4] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 7.4] [Reference Citation Analysis]
366 Lee CK, Mitchell PD, Raza R, Harney S, Wiggins SM, Jonas MM. Validation of Transient Elastography Cut Points to Assess Advanced Liver Fibrosis in Children and Young Adults: The Boston Children's Hospital Experience. J Pediatr 2018;198:84-89.e2. [PMID: 29685617 DOI: 10.1016/j.jpeds.2018.02.062] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
367 Kuroda H, Abe T, Kakisaka K, Fujiwara Y, Yoshida Y, Miyasaka A, Ishida K, Ishida H, Sugai T, Takikawa Y. Visualizing the hepatic vascular architecture using superb microvascular imaging in patients with hepatitis C virus: A novel technique. World J Gastroenterol 2016; 22(26): 6057-6064 [PMID: 27468197 DOI: 10.3748/wjg.v22.i26.6057] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
368 Yeh ML, Huang CF, Huang CI, Dai CY, Lin IH, Liang PC, Hsieh MH, Lin ZY, Chen SC, Huang JF, Chen JJ, Yu ML, Chuang WL. Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients. PLoS One 2019;14:e0220663. [PMID: 31393964 DOI: 10.1371/journal.pone.0220663] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
369 Verloh N, Probst U, Utpatel K, Zeman F, Brennfleck F, Werner JM, Fellner C, Stroszczynski C, Evert M, Wiggermann P, Haimerl M. Influence of hepatic fibrosis and inflammation: Correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging. PLoS One 2019;14:e0215752. [PMID: 31083680 DOI: 10.1371/journal.pone.0215752] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
370 Zhan C, Kannengiesser S, Chandarana H, Fenchel M, Ream J, Shanbhogue KP. MR elastography of liver at 3 Tesla: comparison of gradient-recalled echo (GRE) and spin-echo (SE) echo-planar imaging (EPI) sequences and agreement across stiffness measurements. Abdom Radiol (NY) 2019;44:1825-33. [PMID: 30796479 DOI: 10.1007/s00261-019-01932-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
371 Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology. 2011;259:749-756. [PMID: 21460032 DOI: 10.1148/radiol.11101942.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
372 Li C, Li R, Zhang W. Progress in non-invasive detection of liver fibrosis. Cancer Biol Med 2018;15:124-36. [PMID: 29951337 DOI: 10.20892/j.issn.2095-3941.2018.0018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
373 Suenaga R, Suka M, Hirao T, Hidaka I, Sakaida I, Ishida H. Cost-effectiveness of a "treat-all" strategy using Direct-Acting Antivirals (DAAs) for Japanese patients with chronic hepatitis C genotype 1 at different fibrosis stages. PLoS One 2021;16:e0248748. [PMID: 33793594 DOI: 10.1371/journal.pone.0248748] [Reference Citation Analysis]
374 Heo JY, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Park YN, Ahn SS, Han KH, Kim HS. Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus. Medicine (Baltimore) 2016;95:e3328. [PMID: 27057911 DOI: 10.1097/MD.0000000000003328] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
375 Zhu X, Wang L, Chen E, Chen X, Chen L, Liu L, Lei X, Liu C, Tang H. Prospective Evaluation of FibroScan for the Diagnosis of Hepatic Fibrosis Compared with Liver Biopsy/AST Platelet Ratio Index and FIB-4 in Patients with Chronic HBV Infection. Dig Dis Sci 2011;56:2742-9. [DOI: 10.1007/s10620-011-1659-1] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 5.7] [Reference Citation Analysis]
376 Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol. 2014;20:475-485. [PMID: 24574716 DOI: 10.3748/wpg.v20.i2.475] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
377 Kim KM, Choi WB, Park SH, Yu E, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol. 2007;42:382-388. [PMID: 17530363 DOI: 10.1007/s00535-007-2016-1] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 5.4] [Reference Citation Analysis]
378 Lee JI, Lee HW, Lee KS. Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis. World J Gastroenterol 2019; 25(33): 4959-4969 [PMID: 31543686 DOI: 10.3748/wjg.v25.i33.4959] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
379 Murata A, Amano N, Sato S, Tsuzura H, Tomishima K, Sato S, Matsumoto K, Shimada Y, Iijima K, Genda T. On-treatment Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Level and Risk of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B during Nucleot(s)ide Analogue Therapy. Int J Mol Sci 2020;21:E2051. [PMID: 32192084 DOI: 10.3390/ijms21062051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
380 Wakui N, Nagai H, Matsukiyo Y, Ogino Y, Matsui D, Mukozu T, Kogame M, Matsui T, Daido Y, Momiyama K, Maruyama K, Kudo T, Shinohara M, Ikehara T, Sumino Y, Igarashi Y. Effect of Hepatic Inflammation in Chronic Hepatitis C Infection on Fibrosis Assessment by Arrival Time Parametric Imaging. Ultrasound Q 2018;34:128-32. [PMID: 29634669 DOI: 10.1097/RUQ.0000000000000355] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
381 Hong H, Li J, Jin Y, Li Q, Li W, Wu J, Huang Z. Performance of real-time elastography for the staging of hepatic fibrosis: a meta-analysis. PLoS One. 2014;9:e115702. [PMID: 25541695 DOI: 10.1371/journal.pone.0115702] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
382 Xie S, Qi H, Li Q, Zhang K, Zhang L, Cheng Y, Shen W. Liver injury monitoring, fibrosis staging and inflammation grading using T1rho magnetic resonance imaging: an experimental study in rats with carbon tetrachloride intoxication. BMC Gastroenterol 2020;20:14. [PMID: 31941457 DOI: 10.1186/s12876-020-1161-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
383 Lee YB, Ha Y, Chon YE, Kim MN, Lee JH, Park H, Kim KI, Kim SH, Rim KS, Hwang SG. Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B. Clin Mol Hepatol. 2019;25:52-64. [PMID: 30360031 DOI: 10.3350/cmh.2018.0040] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
384 Yokoo T, Serai SD, Pirasteh A, Bashir MR, Hamilton G, Hernando D, Hu HH, Hetterich H, Kühn JP, Kukuk GM, Loomba R, Middleton MS, Obuchowski NA, Song JS, Tang A, Wu X, Reeder SB, Sirlin CB; RSNA-QIBA PDFF Biomarker Committee. Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis. Radiology 2018;286:486-98. [PMID: 28892458 DOI: 10.1148/radiol.2017170550] [Cited by in Crossref: 107] [Cited by in F6Publishing: 112] [Article Influence: 26.8] [Reference Citation Analysis]
385 Wu Z, Gong Y, Peng J, Zhang X, Tang L. Correlation Between Serum Entecavir Concentration and Virological Response in Patients with Chronic Type B Hepatitis. Med Sci Monit 2019;25:6998-7004. [PMID: 31530794 DOI: 10.12659/MSM.916553] [Reference Citation Analysis]
386 Ismail MH, Pinzani M. Reversal of liver fibrosis. Saudi J Gastroenterol. 2009;15:72-79. [PMID: 19568569 DOI: 10.4103/1319-3767.45072] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 5.2] [Reference Citation Analysis]
387 Burhans MS, Balu N, Schmidt KA, Cromer G, Utzschneider KM, Schur EA, Holte SE, Randolph TW, Kratz M. Impact of the Analytical Approach on the Reliability of MRI-Based Assessment of Hepatic Fat Content. Curr Dev Nutr 2020;4:nzaa171. [PMID: 33381677 DOI: 10.1093/cdn/nzaa171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
388 Martin K, Hatab A, Athwal VS, Jokl E, Piper Hanley K. Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications. Curr Diab Rep 2021;21:8. [PMID: 33544287 DOI: 10.1007/s11892-021-01377-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
389 D'Ambrosio R, Degasperi E, Aghemo A, Fraquelli M, Lampertico P, Rumi MG, Facchetti F, Grassi E, Casazza G, Rosenberg W, Bedossa P, Colombo M. Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon. PLoS One 2016;11:e0155967. [PMID: 27304619 DOI: 10.1371/journal.pone.0155967] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
390 Qayyum A. MR spectroscopy of the liver: principles and clinical applications. Radiographics. 2009;29:1653-1664. [PMID: 19959513 DOI: 10.1148/rg.296095520] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
391 Hines CD, Yu H, Shimakawa A, McKenzie CA, Warner TF, Brittain JH, Reeder SB. Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice. Radiology 2010;254:119-28. [PMID: 20032146 DOI: 10.1148/radiol.09090131] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 5.8] [Reference Citation Analysis]
392 Miyoshi T, Hamaguchi M, Kitagawa N, Hashimoto Y, Fukui M. Correlation between Liver Stiffness by Two-Dimensional Shear Wave Elastography and Waist Circumference in Japanese Local Citizens with Abdominal Obesity. J Clin Med 2021;10:1971. [PMID: 34064337 DOI: 10.3390/jcm10091971] [Reference Citation Analysis]
393 Pradhan B, Hadengue A, Chappuis F, Chaudhary S, Baral D, Gache P, Karki P, Rijal S. Alcoholic liver disease in Nepal: identifying homemade alcohol as a culprit. Clin Exp Gastroenterol 2015;8:183-9. [PMID: 26203269 DOI: 10.2147/CEG.S81321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
394 Deng M, Chen SZ, Yuan J, Chan Q, Zhou J, Wáng YX. Chemical Exchange Saturation Transfer (CEST) MR Technique for Liver Imaging at 3.0 Tesla: an Evaluation of Different Offset Number and an After-Meal and Over-Night-Fast Comparison. Mol Imaging Biol 2016;18:274-82. [PMID: 26391991 DOI: 10.1007/s11307-015-0887-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
395 Srinivasa Babu A, Wells ML, Teytelboym OM, Mackey JE, Miller FH, Yeh BM, Ehman RL, Venkatesh SK. Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions. Radiographics. 2016;36:1987-2006. [PMID: 27689833 DOI: 10.1148/rg.2016160042] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 18.4] [Reference Citation Analysis]
396 Lacasse MC, Tang A, Dubois J, Alvarez F, Spahis S, Chagnon M, Deschênes S, Levy E. Monitoring the efficacy of omega-3 supplementation on liver steatosis and carotid intima-media thickness: a pilot study. Obes Sci Pract 2017;3:201-11. [PMID: 28702213 DOI: 10.1002/osp4.91] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
397 Partovi S, Lu Z, Kessner R, Yu A, Ahmed Y, Patel IJ, Nakamoto DA, Azar N. Contrast enhanced ultrasound guided biopsies of liver lesions not visualized on standard B-mode ultrasound-preliminary experience. J Gastrointest Oncol 2017;8:1056-64. [PMID: 29299367 DOI: 10.21037/jgo.2017.08.17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
398 Perumpail RB, Levitsky J, Wang Y, Lee VS, Karp J, Jin N, Yang GY, Bolster BD, Shah S, Zuehlsdorff S. MRI-guided biopsy to correlate tissue specimens with MR elastography stiffness readings in liver transplants. Acad Radiol. 2012;19:1121-1126. [PMID: 22877987 DOI: 10.1016/j.acra.2012.05.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
399 Nobili V, Alisi A, Vania A, Tiribelli C, Pietrobattista A, Bedogni G. The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease. BMC Med. 2009;7:21. [PMID: 19409076 DOI: 10.1186/1741-7015-7-21] [Cited by in Crossref: 82] [Cited by in F6Publishing: 80] [Article Influence: 6.8] [Reference Citation Analysis]
400 Skoczylas K, Pawełas A. Ultrasound imaging of the liver and bile ducts - expectations of a clinician. J Ultrason 2015;15:292-306. [PMID: 26673784 DOI: 10.15557/JoU.2015.0026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
401 Chen Y, Li Y, Li N, Fan X, Li C, Zhang P, Han Q, Liu Z. A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels. Dis Markers 2018;2018:3924732. [PMID: 30405859 DOI: 10.1155/2018/3924732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
402 Lee HH, Seo YS, Um SH, Won NH, Yoo H, Jung ES, Kwon YD, Park S, Keum B, Kim YS. Usefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver disease. J Korean Med Sci. 2010;25:67-74. [PMID: 20052350 DOI: 10.3346/jkms.2010.25.1.67] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
403 Kamada Y, Morishita K, Koseki M, Nishida M, Asuka T, Naito Y, Yamada M, Takamatsu S, Sakata Y, Takehara T, Miyoshi E. Serum Mac-2 Binding Protein Levels Associate with Metabolic Parameters and Predict Liver Fibrosis Progression in Subjects with Fatty Liver Disease: A 7-Year Longitudinal Study. Nutrients 2020;12:E1770. [PMID: 32545650 DOI: 10.3390/nu12061770] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
404 Sanai FM, Keeffe EB. Liver biopsy for histological assessment: The case against. Saudi J Gastroenterol. 2010;16:124-132. [PMID: 20339187 DOI: 10.4103/1319-3767.61244] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
405 Corbin IR, Buist R, Peeling J, Zhang M, Uhanova J, Minuk GY. Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease. Gut. 2003;52:1046-1053. [PMID: 12801965 DOI: 10.1136/gut.52.7.1046] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
406 Dioguardi N, Grizzi F, Franceschini B, Bossi P, Russo C. Liver fibrosis and tissue architectural change measurement using fractal-rectified metrics and Hurst’s exponent. World J Gastroenterol 2006; 12(14): 2187-2194 [PMID: 16610019 DOI: 10.3748/wjg.v12.i14.2187] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
407 Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2014; 20(2): 475-485 [PMID: 24574716 DOI: 10.3748/wjg.v20.i2.475] [Cited by in CrossRef: 256] [Cited by in F6Publishing: 235] [Article Influence: 36.6] [Reference Citation Analysis]
408 Carvalho-Filho RJ, Feldner ACC, Silva AEB, Ferraz MLG. Management of hepatitis C in patients with chronic kidney disease. World J Gastroenterol 2015; 21(2): 408-422 [PMID: 25593456 DOI: 10.3748/wjg.v21.i2.408] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
409 Kircheis G, Sagir A, Vogt C, vom Dahl S, Kubitz R, Häussinger D. Evaluation of acoustic radiation force impulse imaging for determination of liver stiffness using transient elastography as a reference. World J Gastroenterol 2012; 18(10): 1077-1084 [PMID: 22416182 DOI: 10.3748/wjg.v18.i10.1077] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
410 Cacciapuoti F, Scognamiglio A, Palumbo R, Forte R, Cacciapuoti F. Silymarin in non alcoholic fatty liver disease. World J Hepatol 2013; 5(3): 109-113 [PMID: 23556042 DOI: 10.4254/wjh.v5.i3.109] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.9] [Reference Citation Analysis]
411 Köksal İ, Yılmaz G, Parlak M, Demirdal T, Kınıklı S, Candan M, Kaya A, Akhan S, Aydoğdu Ö, Turgut H, Gürbüz Y, Dağlı Ö, Gökal AA, Güner R, Kuruüzüm Z, Tarakçı H, Beslen N, Erdoğan S, Özdener F, Study Group TCHC. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study. Turk J Gastroenterol 2018;29:464-72. [PMID: 30249562 DOI: 10.5152/tjg.2018.16597] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
412 Yu SJ, Lee JH, Chung GE, Lee CH, Cho EJ, Jang ES, Kwak MS, Kim YJ, Yoon JH, Jang JJ, Lee HS. Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma. Korean J Hepatol 2010;16:389-96. [PMID: 21415583 DOI: 10.3350/kjhep.2010.16.4.389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
413 Shah N, Nelson JE, Kowdley KV. MicroRNAs in Liver Disease: Bench to Bedside. J Clin Exp Hepatol. 2013;3:231-242. [PMID: 25755505 DOI: 10.1016/j.jceh.2013.09.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
414 Tag-Adeen M, Omar MZ, Abd-Elsalam FM, Hasaneen A, Mohamed MA, Elfeky HM, Said EM, Abdul-Aziz B, Osman AH, Ahmed ES, Osman GS, Abdul-Samie T. Assessment of liver fibrosis in Egyptian chronic hepatitis B patients: A comparative study including 5 noninvasive indexes. Medicine (Baltimore) 2018;97:e9781. [PMID: 29419671 DOI: 10.1097/MD.0000000000009781] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
415 Deng M, Zhao F, Yuan J, Ahuja AT, Wang YX. Liver T1ρ MRI measurement in healthy human subjects at 3 T: a preliminary study with a two-dimensional fast-field echo sequence. Br J Radiol 2012;85:e590-5. [PMID: 22422392 DOI: 10.1259/bjr/98745548] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
416 Heyens LJM, Busschots D, Koek GH, Robaeys G, Francque S. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front Med (Lausanne) 2021;8:615978. [PMID: 33937277 DOI: 10.3389/fmed.2021.615978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
417 Bardou-Jacquet E, Legros L, Soro D, Latournerie M, Guillygomarc’h A, Lan CL, Brissot P, Guyader D, Moirand R. Effect of alcohol consumption on liver stiffness measured by transient elastography. World J Gastroenterol 2013; 19(4): 516-522 [PMID: 23382630 DOI: 10.3748/wjg.v19.i4.516] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
418 Yamasaki K, Tateyama M, Abiru S, Komori A, Nagaoka S, Saeki A, Hashimoto S, Sasaki R, Bekki S, Kugiyama Y, Miyazoe Y, Kuno A, Korenaga M, Togayachi A, Ocho M, Mizokami M, Narimatsu H, Yatsuhashi H. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology. 2014;60:1563-1570. [PMID: 25042054 DOI: 10.1002/hep.27305] [Cited by in Crossref: 153] [Cited by in F6Publishing: 144] [Article Influence: 21.9] [Reference Citation Analysis]
419 Wagner M, Corcuera-Solano I, Lo G, Esses S, Liao J, Besa C, Chen N, Abraham G, Fung M, Babb JS, Ehman RL, Taouli B. Technical Failure of MR Elastography Examinations of the Liver: Experience from a Large Single-Center Study. Radiology 2017;284:401-12. [PMID: 28045604 DOI: 10.1148/radiol.2016160863] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 19.5] [Reference Citation Analysis]
420 Singh S, Venkatesh SK, Loomba R, Wang Z, Sirlin C, Chen J, Yin M, Miller FH, Low RN, Hassanein T, Godfrey EM, Asbach P, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol. 2016;26:1431-1440. [PMID: 26314479 DOI: 10.1007/s00330-015-3949-z] [Cited by in Crossref: 118] [Cited by in F6Publishing: 105] [Article Influence: 19.7] [Reference Citation Analysis]
421 Ku NO, Strnad P, Bantel H, Omary MB. Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver. Hepatology 2016;64:966-76. [PMID: 26853542 DOI: 10.1002/hep.28493] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 11.2] [Reference Citation Analysis]
422 Obara N, Ueno Y, Fukushima K, Nakagome Y, Kakazu E, Kimura O, Wakui Y, Kido O, Ninomiya M, Kogure T. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases. J Gastroenterol. 2008;43:720-728. [PMID: 18807134 DOI: 10.1007/s00535-008-2225-2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 4.4] [Reference Citation Analysis]
423 Rath T, Hage L, Kügler M, Menendez Menendez K, Zachoval R, Naehrlich L, Schulz R, Roderfeld M, Roeb E. Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease. PLoS One. 2013;8:e58955. [PMID: 23516586 DOI: 10.1371/journal.pone.0058955] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
424 Liu GJ, Lu MD. Diagnosis of liver cirrhosis with contrast-enhanced ultrasound. World J Radiol 2010; 2(1): 32-36 [PMID: 21160737 DOI: 10.4329/wjr.v2.i1.32] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
425 Mo YH, Chen HL, Hsu WM, Chang CH, Peng SS. A noninvasive index to predict liver cirrhosis in biliary atresia. Pediatr Radiol 2021;51:257-64. [PMID: 32964265 DOI: 10.1007/s00247-020-04823-w] [Reference Citation Analysis]
426 Limketkai BN, Mehta SH, Sutcliffe CG, Higgins YM, Torbenson MS, Brinkley SC, Moore RD, Thomas DL, Sulkowski MS. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA. 2012;308:370-378. [PMID: 22820790 DOI: 10.1001/jama.2012.7844] [Cited by in Crossref: 144] [Cited by in F6Publishing: 142] [Article Influence: 16.0] [Reference Citation Analysis]
427 Ekiz F, Yuksel İ, Arikök AT, Yilmaz B, Altinbas A, Aktas B, Deveci M, Basar O, Coban S, Yuksel O. Will a second biopsy sample affect treatment decisions in patients with chronic hepatitis B? Hepatol Int 2016;10:602-5. [PMID: 26416085 DOI: 10.1007/s12072-015-9666-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
428 Shah AG, Smith PG, Sterling RK. Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT. Dig Dis Sci 2011;56:3038-44. [PMID: 21526398 DOI: 10.1007/s10620-011-1710-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
429 Sharma P, Altbach M, Galons JP, Kalb B, Martin DR. Measurement of liver fat fraction and iron with MRI and MR spectroscopy techniques. Diagn Interv Radiol 2014;20:17-26. [PMID: 24047718 DOI: 10.5152/dir.2013.13124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
430 Zhou IY, Catalano OA, Caravan P. Advances in functional and molecular MRI technologies in chronic liver diseases. J Hepatol 2020;73:1241-54. [PMID: 32585160 DOI: 10.1016/j.jhep.2020.06.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
431 Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, Eisele S, Stickel F, Longerich T, Schirmacher P. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol. 2010;16:966-972. [PMID: 20180235 DOI: 10.3748/wjg.16.966] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
432 Yen YH, Chen JB, Cheng BC, Chen JF, Chang KC, Tseng PL, Wu CK, Tsai MC, Lin MT, Hu TH. Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study. PLoS One 2017;12:e0176027. [PMID: 28426815 DOI: 10.1371/journal.pone.0176027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
433 Mok SRS, Diehl DL, Johal AS, Khara HS, Confer BD, Mudireddy PR, Kovach AH, Diehl MM, Kirchner HL, Chen ZE. Endoscopic ultrasound-guided biopsy in chronic liver disease: a randomized comparison of 19-G FNA and 22-G FNB needles. Endosc Int Open. 2019;7:E62-E71. [PMID: 30648141 DOI: 10.1055/a-0655-7462] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
434 Uto H, Mawatari S, Kumagai K, Ido A, Tsubouchi H. Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels. Hepat Mon 2012;12:77-84. [PMID: 22509183 DOI: 10.5812/hepatmon.829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
435 Calle-Toro JS, Serai SD, Hartung EA, Goldberg DJ, Bolster BD Jr, Darge K, Anupindi SA. Magnetic resonance elastography SE-EPI vs GRE sequences at 3T in a pediatric population with liver disease. Abdom Radiol (NY) 2019;44:894-902. [PMID: 30600386 DOI: 10.1007/s00261-018-1884-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
436 Fujita K, Oura K, Yoneyama H, Shi T, Takuma K, Nakahara M, Tadokoro T, Nomura T, Morishita A, Tsutsui K, Himoto T, Masaki T. Albumin-bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C. Hepatol Res 2019;49:731-42. [PMID: 30892804 DOI: 10.1111/hepr.13333] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
437 Geng XX, Huang RG, Lin JM, Jiang N, Yang XX. Transient elastography in clinical detection of liver cirrhosis: A systematic review and meta-analysis. Saudi J Gastroenterol. 2016;22:294-303. [PMID: 27488324 DOI: 10.4103/1319-3767.187603] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
438 Vali Y, Lee J, Boursier J, Spijker R, Verheij J, Brosnan MJ, Anstee QM, Bossuyt PM, Zafarmand MH, On Behalf Of The Litmus Systematic Review Team. FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis. J Clin Med 2021;10:2415. [PMID: 34072480 DOI: 10.3390/jcm10112415] [Reference Citation Analysis]
439 Yoon SH, Lee KH, Kim SY, Kim YH, Kim JH, Lee SH, Kim TK. Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound. Eur Radiol. 2010;20:2047-2056. [PMID: 20309559 DOI: 10.1007/s00330-010-1757-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
440 Hsu C, Caussy C, Imajo K, Chen J, Singh S, Kaulback K, Le MD, Hooker J, Tu X, Bettencourt R, Yin M, Sirlin CB, Ehman RL, Nakajima A, Loomba R. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants. Clin Gastroenterol Hepatol 2019;17:630-637.e8. [PMID: 29908362 DOI: 10.1016/j.cgh.2018.05.059] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 31.3] [Reference Citation Analysis]
441 Wong GL. Prediction of fibrosis progression in chronic viral hepatitis. Clin Mol Hepatol 2014;20:228-36. [PMID: 25320725 DOI: 10.3350/cmh.2014.20.3.228] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
442 Regnell SE, Lernmark Å. Hepatic steatosis in type 1 diabetes. Rev Diabet Stud 2011;8:454-67. [PMID: 22580727 DOI: 10.1900/RDS.2011.8.454] [Cited by in Crossref: 59] [Cited by in F6Publishing: 24] [Article Influence: 6.6] [Reference Citation Analysis]
443 Farrington EA, Maskell G, Hussaini HS. Feasibility and experience of nurse-led ultrasound-guided percutaneous liver biopsy. Frontline Gastroenterol 2012;3:187-90. [PMID: 28839662 DOI: 10.1136/flgastro-2012-100154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
444 Pacana T, Sanyal AJ. Recent advances in understanding/management of non-alcoholic steatohepatitis. F1000Prime Rep. 2015;7:28. [PMID: 25926979 DOI: 10.12703/p7-28] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
445 Dönmez H, Kahriman G, Ozcan N, Mavili E, Deniz K. Transjugular liver biopsy: results of 97 patients. Balkan Med J 2012;29:129-32. [PMID: 25206981 DOI: 10.5152/balkanmedj.2011.022] [Reference Citation Analysis]
446 Danin PE, Anty R, Patouraux S, Raucoules-Aimé M, Gugenheim J, Tran A, Gual P, Iannelli A. Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery. Obes Surg 2018;28:735-42. [PMID: 28875438 DOI: 10.1007/s11695-017-2914-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
447 Verloh N, Haimerl M, Zeman F, Schlabeck M, Barreiros A, Loss M, Schreyer AG, Stroszczynski C, Fellner C, Wiggermann P. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla. Eur Radiol. 2014;24:1013-1019. [PMID: 24531844 DOI: 10.1007/s00330-014-3108-y] [Cited by in Crossref: 91] [Cited by in F6Publishing: 80] [Article Influence: 13.0] [Reference Citation Analysis]
448 Yao M, Wang L, Leung PSC, Li Y, Liu S, Wang L, Guo X, Zhou G, Yan Y, Guan G, Chen X, Bowlus CL, Liu T, Jia J, Gershwin ME, Ma X, Zhao J, Lu F. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review. Clin Rev Allergy Immunol. 2018;54:282-294. [PMID: 29256057 DOI: 10.1007/s12016-017-8655-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
449 Kolhe KM, Amarapurkar A, Parikh P, Chaubal A, Chauhan S, Khairnar H, Walke S, Ingle M, Pandey V, Shukla A. Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population. BMJ Open Gastroenterol. 2019;6:e000288. [PMID: 31275584 DOI: 10.1136/bmjgast-2019-000288] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
450 Ueda N, Kawaoka T, Imamura M, Aikata H, Nakahara T, Murakami E, Tsuge M, Hiramatsu A, Hayes CN, Yokozaki M, Chayama K. Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection. BMC Gastroenterol 2020;20:314. [PMID: 32977741 DOI: 10.1186/s12876-020-01459-w] [Reference Citation Analysis]
451 Ishibashi H, Maruyama H, Takahashi M, Shimada T, Kamesaki H, Fujiwara K, Imazeki F, Yokosuka O. Demonstration of intrahepatic accumulated microbubble on ultrasound represents the grade of hepatic fibrosis. Eur Radiol 2012;22:1083-90. [PMID: 22207268 DOI: 10.1007/s00330-011-2346-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
452 Yoo H, Lee JM, Yoon JH, Lee DH, Chang W, Han JK. Prospective Comparison of Liver Stiffness Measurements between Two Point Shear Wave Elastography Methods: Virtual Touch Quantification and Elastography Point Quantification. Korean J Radiol. 2016;17:750-757. [PMID: 27587964 DOI: 10.3348/kjr.2016.17.5.750] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
453 Jiang H, Zheng T, Duan T, Chen J, Song B. Non-invasive in vivo Imaging Grading of Liver Fibrosis. J Clin Transl Hepatol. 2018;6:198-207. [PMID: 29951365 DOI: 10.14218/jcth.2017.00038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
454 Godfrey EM, Patterson AJ, Priest AN, Davies SE, Joubert I, Krishnan AS, Griffin N, Shaw AS, Alexander GJ, Allison ME, Griffiths WJH, Gimson AES, Lomas DJ. A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur Radiol 2012;22:2790-7. [DOI: 10.1007/s00330-012-2527-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
455 Armstrong MJ, Barton D, Gaunt P, Hull D, Guo K, Stocken D, Gough SC, Tomlinson JW, Brown RM, Hübscher SG. Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial. BMJ Open. 2013;3:e003995. [PMID: 24189085 DOI: 10.1136/bmjopen-2013-003995] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
456 Kim SU, Park JY, Kim do Y, Ahn SH, Choi EH, Seok JY, Lee JM, Park YN, Chon CY, Han KH. Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression. Hepatol Int. 2010;4:673-680. [PMID: 21286337 DOI: 10.1007/s12072-010-9201-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
457 Bae JS, Lee DH, Lee JY, Kim H, Yu SJ, Lee JH, Cho EJ, Lee YB, Han JK, Choi BI. Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique. Eur Radiol. 2019;. [PMID: 31175413 DOI: 10.1007/s00330-019-06272-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
458 Torres HA, Shigle TL, Hammoudi N, Link JT, Samaniego F, Kaseb A, Mallet V. The oncologic burden of hepatitis C virus infection: A clinical perspective. CA Cancer J Clin. 2017;67:411-431. [PMID: 28683174 DOI: 10.3322/caac.21403] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 12.3] [Reference Citation Analysis]
459 Caussy C, Johansson L. Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Endocrinol Diabetes Metab. 2020;3:e00134. [PMID: 33102797 DOI: 10.1002/edm2.134] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
460 Mueller S, Sandrin L. Liver stiffness: a novel parameter for the diagnosis of liver disease. Hepat Med. 2010;2:49-67. [PMID: 24367208 DOI: 10.2147/hmer.s7394] [Cited by in Crossref: 196] [Cited by in F6Publishing: 81] [Article Influence: 17.8] [Reference Citation Analysis]
461 Pacifico L, Poggiogalle E, Cantisani V, Menichini G, Ricci P, Ferraro F, Chiesa C. Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge. World J Hepatol 2010; 2(7): 275-288 [PMID: 21161009 DOI: 10.4254/wjh.v2.i7.275] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
462 Wang Z, Ai X, Zhang Z, Wang Y, Wu X, Haindl R, Yeow EKL, Drexler W, Gao M, Xing B. NIR nanoprobe-facilitated cross-referencing manifestation of local disease biology for dynamic therapeutic response assessment. Chem Sci 2019;11:803-11. [PMID: 34123056 DOI: 10.1039/c9sc04909f] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
463 Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, Munteanu M, Massard J, Benhamou Y, Ratziu V. Assessment of liver fibrosis: noninvasive means. Saudi J Gastroenterol. 2008;14:163-173. [PMID: 19568532 DOI: 10.4103/1319-3767.43273] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
464 Lahousen T, Hegenbarth K, Ille R, Lipp RW, Krause R, Little RR, Schnedl WJ. Determination of glycated hemoglobin in patients with advanced liver disease. World J Gastroenterol 2004; 10(15): 2284-2286 [PMID: 15259084 DOI: 10.3748/wjg.v10.i15.2284] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
465 Kim DY, Song KJ, Kim SU, Yoo EJ, Park JY, Ahn SH, Han KH. Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model. Onco Targets Ther. 2013;6:1463-1469. [PMID: 24204161 DOI: 10.2147/ott.s51986] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
466 Heba ER, Desai A, Zand KA, Hamilton G, Wolfson T, Schlein AN, Gamst A, Loomba R, Sirlin CB, Middleton MS. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. J Magn Reson Imaging. 2016;43:398-406. [PMID: 26201284 DOI: 10.1002/jmri.25006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
467 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol 2020;26:83-127. [PMID: 31918536 DOI: 10.3350/cmh.2019.0010n] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
468 Behrens G, Ferral H. Transjugular liver biopsy. Semin Intervent Radiol. 2012;29:111-117. [PMID: 23729981 DOI: 10.1055/s-0032-1312572] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
469 Huang JY. Role of EUS-guided liver biopsy in benign parenchymal disease (with video). Endosc Ultrasound. 2018;7:236-239. [PMID: 30117485 DOI: 10.4103/eus.eus_33_18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
470 Eskandari A, Koo P, Bang H, Gui D, Urayama S. Comparison of Endoscopic Ultrasound Biopsy Needles for Endoscopic Ultrasound-Guided Liver Biopsy. Clin Endosc 2019;52:347-52. [PMID: 31288504 DOI: 10.5946/ce.2019.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
471 Chiavaroli R, Grima PF, Calabrese P, Grima P. Routine ultrasound-guided liver biopsy versus echo-assisted procedure in viral chronic hepatitis. Radiol Med 2008;113:992-8. [PMID: 18818984 DOI: 10.1007/s11547-008-327-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
472 Malik R, Kennedy P, Suri D, Brown A, Goldin R, Main J, Thomas H, Thursz M. The role of liver fibrosis assessment in the management of patients with chronic hepatitis B infection: lessons learned from a single centre experience. Hepat Res Treat 2011;2011:524027. [PMID: 22114737 DOI: 10.1155/2011/524027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
473 Van Ha TG. Liver biopsy in liver transplant recipients. Semin Intervent Radiol 2004;21:271-4. [PMID: 21331138 DOI: 10.1055/s-2004-861561] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
474 Mancini M, Salomone Megna A, Ragucci M, De Luca M, Marino Marsilia G, Nardone G, Coccoli P, Prinster A, Mannelli L, Vergara E, Monti S, Liuzzi R, Incoronato M. Reproducibility of shear wave elastography (SWE) in patients with chronic liver disease. PLoS One. 2017;12:e0185391. [PMID: 29023554 DOI: 10.1371/journal.pone.0185391] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
475 Jin YJ, Shim JH, Kim GA, Yu E, Kim KM, Lim YS, Lee HC. Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infection. BMJ Open 2014;4:e006255. [PMID: 25431223 DOI: 10.1136/bmjopen-2014-006255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
476 Cui E, Long W, Wu J, Li Q, Ma C, Lei Y, Lin F. Predicting the stages of liver fibrosis with multiphase CT radiomics based on volumetric features. Abdom Radiol (NY) 2021;46:3866-76. [PMID: 33751193 DOI: 10.1007/s00261-021-03051-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
477 Zheng S, Tong M, Dong L, Du C, Zheng X, Wang L, Huang P, Liu W, Lin M, Liu C. Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome. Endocr Connect 2020;9:154-62. [PMID: 31910158 DOI: 10.1530/EC-19-0559] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
478 Lee JH, Chae HB, Seo EK, Jeon WJ, Jeong HW, Shin YM, Bae JW, Kwon SK, Bae IH, Shim WS, Shin DI, Sung R, Kim JY. Successful Hemostasis with Recombinant Activated Factor VII in a Patient with Massive Hepatic Subcapsular Hematoma. Case Rep Gastroenterol 2009;3:10-5. [PMID: 20651958 DOI: 10.1159/000203078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
479 Li N, Puga Yung GL, Pradier A, Toso C, Giostra E, Morard I, Spahr L, Seebach JD. NK cell isolation from liver biopsies: phenotypic and functional analysis of low cell numbers by flow cytometry. Front Immunol. 2013;4:61. [PMID: 23482713 DOI: 10.3389/fimmu.2013.00061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
480 Kuo YH, Lu SN, Chen CH, Chang KC, Hung CH, Tai WC, Tsai MC, Tseng PL, Hu TH, Wang JH. The changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapy. PLoS One. 2014;9:e93160. [PMID: 24682088 DOI: 10.1371/journal.pone.0093160] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
481 Orăşan OH, Sava M, Iancu M, Cozma A, Saplonţai-Pop A, Sarlea Ţărmure S, Lungoci C, Orăşan RA, Patiu IM, Dumitraşcu DL. Serum hyaluronic acid in chronic viral hepatitis B and C: a biomarker for assessing liver fibrosis in chronic hemodialysis patients. Int Urol Nephrol 2015;47:1209-17. [PMID: 26025064 DOI: 10.1007/s11255-015-1017-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
482 Chaudhry AA, Sulkowski MS, Chander G, Moore RD. Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort. HIV Med. 2009;10:133-142. [PMID: 19207596 DOI: 10.1111/j.1468-1293.2008.00662.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
483 Ferraioli G, Tinelli C, Lissandrin R, Zicchetti M, Bello BD, Filice G, Filice C. Point shear wave elastography method for assessing liver stiffness. World J Gastroenterol 2014; 20(16): 4787-4796 [PMID: 24782633 DOI: 10.3748/wjg.v20.i16.4787] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 72] [Article Influence: 12.3] [Reference Citation Analysis]
484 Kubo K, Kawakami H, Kuwatani M, Nishida M, Kawakubo K, Kawahata S, Taya Y, Kubota Y, Amano T, Shirato H, Sakamoto N. Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort studya prospective cohort study. BMC Gastroenterol 2016;16:65. [PMID: 27391646 DOI: 10.1186/s12876-016-0479-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
485 Ueno T, Kodama T, Noguchi Y, Saka R, Takama Y, Tazuke Y, Bessho K, Okuyama H. Clinical implications of serum Mac-2-binding protein (M2BPGi) during regular follow-up of patients with biliary atresia. Pediatr Surg Int 2018;34:1065-71. [PMID: 30128700 DOI: 10.1007/s00383-018-4317-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
486 Park HS, Kim YJ, Yu MH, Choe WH, Jung SI, Jeon HJ. Three-Tesla magnetic resonance elastography for hepatic fibrosis: Comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging. World J Gastroenterol 2014; 20(46): 17558-17567 [PMID: 25516671 DOI: 10.3748/wjg.v20.i46.17558] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
487 Mansoor S, Yerian L, Kohli R, Xanthakos S, Angulo P, Ling S, Lopez R, Christine CK, Feldstein AE, Alkhouri N. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease. Dig Dis Sci 2015;60:1440-7. [PMID: 25540086 DOI: 10.1007/s10620-014-3494-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
488 Fujita K, Masaki T. Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept "Compensated Advanced Chronic Liver Disease". J Clin Med 2021;10:3340. [PMID: 34362121 DOI: 10.3390/jcm10153340] [Reference Citation Analysis]
489 Watanabe H, Kanematsu M, Kitagawa T, Suzuki Y, Kondo H, Goshima S, Kajita K, Bae KT, Hirose Y, Miotani S, Zhou X, Fujita H. MR elastography of the liver at 3 T with cine-tagging and bending energy analysis: preliminary results. Eur Radiol 2010;20:2381-9. [PMID: 20440504 DOI: 10.1007/s00330-010-1800-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
490 Obrzut M, Atamaniuk V, Obrzut B, Ehman R, Cholewa M, Rzucidło M, Pozaruk A, Gutkowski K. Normative values for magnetic resonance elastography-based liver stiffness in a healthy population. Pol Arch Intern Med 2019;129:321-6. [PMID: 30793705 DOI: 10.20452/pamw.4456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
491 Kobayashi K, Nakao H, Nishiyama T, Lin Y, Kikuchi S, Kobayashi Y, Yamamoto T, Ishii N, Ohashi T, Satoh K. Diagnostic accuracy of real-time tissue elastography for the staging of liver fibrosis: a meta-analysis. Eur Radiol. 2015;25:230-238. [PMID: 25149296 DOI: 10.1007/s00330-014-3364-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
492 Borman MA, Ladak F, Crotty P, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Duarte-Rojo A, Elkashab M, Myers RP. The Fatty Liver Index has limited utility for the detection and quantification of hepatic steatosis in obese patients. Hepatol Int 2013;7:592-9. [PMID: 26201792 DOI: 10.1007/s12072-012-9401-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
493 Qu HQ, Li Q, Grove ML, Lu Y, Pan JJ, Rentfro AR, Bickel PE, Fallon MB, Hanis CL, Boerwinkle E. Population-based risk factors for elevated alanine aminotransferase in a South Texas Mexican-American population. Arch Med Res. 2012;43:482-488. [PMID: 22959976 DOI: 10.1016/j.arcmed.2012.08.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
494 Gorka-Dynysiewicz J, Pazgan-Simon M, Zuwala-Jagiello J. Pentraxin 3 Detects Clinically Significant Fibrosis in Patients with Chronic Viral Hepatitis C. Biomed Res Int 2019;2019:2639248. [PMID: 31061822 DOI: 10.1155/2019/2639248] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
495 Chang JW, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SU. Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy. Gut Liver 2021;15:117-27. [PMID: 32066210 DOI: 10.5009/gnl19301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
496 Wang K, Lu X, Zhou H, Gao Y, Zheng J, Tong M, Wu C, Liu C, Huang L, Jiang T, Meng F, Lu Y, Ai H, Xie XY, Yin LP, Liang P, Tian J, Zheng R. Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study. Gut. 2019;68:729-741. [PMID: 29730602 DOI: 10.1136/gutjnl-2018-316204] [Cited by in Crossref: 130] [Cited by in F6Publishing: 125] [Article Influence: 43.3] [Reference Citation Analysis]
497 Wei B, Feng S, Chen E, Li D, Wang T, Gou Y, Yang T, Zhang D, Tao C, Tang H. M2BPGi as a potential diagnostic tool of cirrhosis in Chinese patients with Hepatitis B virus infection. J Clin Lab Anal 2018;32. [PMID: 28544156 DOI: 10.1002/jcla.22261] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
498 DeWitt J, Cho CM, Lin J, Al-Haddad M, Canto MI, Salamone A, Hruban RH, Messallam AA, Khashab MA. Comparison of EUS-guided tissue acquisition using two different 19-gauge core biopsy needles: a multicenter, prospective, randomized, and blinded study. Endosc Int Open. 2015;3:E471-E478. [PMID: 26528504 DOI: 10.1055/s-0034-1392222] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
499 Iijima M, Arisaka T, Yamamiya A, Tominaga K, Nagashima K, Kanamori A, Masuyama S, Majima Y, Goda K, Ishida K, Irisawa A. Feasibility and Safety of Transjugular Liver Biopsy for Japanese Patients with Chronic Liver Diseases. Diagnostics (Basel) 2021;11:131. [PMID: 33467069 DOI: 10.3390/diagnostics11010131] [Reference Citation Analysis]
500 Parekh PJ, Majithia R, Diehl DL, Baron TH. Endoscopic ultrasound-guided liver biopsy. Endosc Ultrasound. 2015;4:85-91. [PMID: 26020041 DOI: 10.4103/2303-9027.156711] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
501 Valva P, Casciato P, Diaz Carrasco JM, Gadano A, Galdame O, Galoppo MC, Mullen E, De Matteo E, Preciado MV. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection. PLoS One. 2011;6:e23218. [PMID: 21858035 DOI: 10.1371/journal.pone.0023218] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
502 Liang LB, Zhu X, Yan LB, Du LY, Liu C, Chen LY, Liao J, Tang H. Serum hepatitis B surface antigen titer and transient elastography in screening for insignificant fibrosis in HBeAg-positive chronic hepatitis B patients. Ther Clin Risk Manag 2015;11:229-35. [PMID: 25709465 DOI: 10.2147/TCRM.S73827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
503 Baudi I, Inoue T, Tanaka Y. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi. Int J Mol Sci. 2020;21. [PMID: 32023902 DOI: 10.3390/ijms21030949] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
504 Ghent CN. Percutaneous liver biopsy: reflections and refinements. Can J Gastroenterol 2006;20:75-9. [PMID: 16482231 DOI: 10.1155/2006/452942] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
505 Tamaki N, Kurosaki M, Yasui Y, Tsuchiya K, Izumi N. Attenuation coefficient (ATT) measurement for liver fat quantification in chronic liver disease. J Med Ultrason (2001) 2021. [PMID: 34165645 DOI: 10.1007/s10396-021-01103-4] [Reference Citation Analysis]
506 Valva P, Ríos DA, De Matteo E, Preciado MV. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage. World J Gastroenterol 2016; 22(4): 1367-1381 [PMID: 26819506 DOI: 10.3748/wjg.v22.i4.1367] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
507 Seko Y, Yano K, Takahashi A, Okishio S, Kataoka S, Okuda K, Umemura A, Yamaguchi K, Moriguchi M, Tanaka S, Itoh Y. The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan. Diagnostics (Basel) 2020;10:E842. [PMID: 33086582 DOI: 10.3390/diagnostics10100842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
508 Malaguarnera G, Cataudella E, Giordano M, Nunnari G, Chisari G, Malaguarnera M. Toxic hepatitis in occupational exposure to solvents. World J Gastroenterol 2012; 18(22): 2756-2766 [PMID: 22719183 DOI: 10.3748/wjg.v18.i22.2756] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 58] [Article Influence: 8.9] [Reference Citation Analysis]
509 Fitzpatrick E, Dhawan A. Noninvasive biomarkers in non-alcoholic fatty liver disease: Current status and a glimpse of the future. World J Gastroenterol 2014; 20(31): 10851-10863 [PMID: 25152587 DOI: 10.3748/wjg.v20.i31.10851] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 59] [Article Influence: 9.7] [Reference Citation Analysis]
510 Mada PK, Malus ME, Saldaña Koppel DA, Adley S, Moore M, Alam MJ, Feldman M. Predicting Liver Fibrosis in the Hepatitis C Population: Concordance Analysis Between Noninvasive Scoring Systems and Percutaneous Liver Biopsy. Cureus 2020;12:e10376. [PMID: 33062499 DOI: 10.7759/cureus.10376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
511 Chang Y, Kim JI, Lee B, Kim SG, Jung MJ, Kim YS, Jeong SW, Jang JY, Yoo JJ. Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years. Clin Mol Hepatol 2020;26:318-27. [PMID: 32447878 DOI: 10.3350/cmh.2019.0019n] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
512 Zhang GL, Zhao QY, Lin CS, Hu ZX, Zhang T, Gao ZL. Transient Elastography and Ultrasonography: Optimal Evaluation of Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease. Biomed Res Int 2019;2019:3951574. [PMID: 30809540 DOI: 10.1155/2019/3951574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
513 Fang J, Chang NF, Tsui PH. Performance Evaluations on Using Entropy of Ultrasound Log-Compressed Envelope Images for Hepatic Steatosis Assessment: An In Vivo Animal Study. Entropy (Basel) 2018;20:E120. [PMID: 33265211 DOI: 10.3390/e20020120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
514 Urasaki Y, Zhang C, Cheng JX, Le TT. Quantitative Assessment of Liver Steatosis and Affected Pathways with Molecular Imaging and Proteomic Profiling. Sci Rep 2018;8:3606. [PMID: 29483581 DOI: 10.1038/s41598-018-22082-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
515 Lee DH. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification. Clin Mol Hepatol 2017;23:290-301. [PMID: 28994271 DOI: 10.3350/cmh.2017.0042] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 10.8] [Reference Citation Analysis]
516 Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging. 2011;34:729-749. [PMID: 22025886 DOI: 10.1002/jmri.22775] [Cited by in Crossref: 52] [Cited by in F6Publishing: 266] [Article Influence: 5.2] [Reference Citation Analysis]
517 Wu CH, Ho MC, Jeng YM, Liang PC, Hu RH, Lai HS, Shih TT. Assessing hepatic fibrosis: comparing the intravoxel incoherent motion in MRI with acoustic radiation force impulse imaging in US. EurRadiol. 2015;25:3552-3559. [PMID: 25991478 DOI: 10.1007/s00330-015-3774-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
518 Verloh N, Utpatel K, Haimerl M, Zeman F, Beyer L, Fellner C, Brennfleck F, Dahlke MH, Stroszczynski C, Evert M, Wiggermann P. Detecting liver fibrosis with Gd-EOB-DTPA-enhanced MRI: A confirmatory study. Sci Rep 2018;8:6207. [PMID: 29670136 DOI: 10.1038/s41598-018-24316-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
519 Kemp SD, Zimmerman KL, Panciera DL, Monroe WE, Leib MS, Lanz OI. A comparison of liver sampling techniques in dogs. J Vet Intern Med 2015;29:51-7. [PMID: 25417960 DOI: 10.1111/jvim.12508] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
520 Mummadi RR, Petersen JR, Xiao SY, Snyder N. Role of simple biomarkers in predicting fibrosis progression in HCV infection. World J Gastroenterol 2010; 16(45): 5710-5715 [PMID: 21128320 DOI: 10.3748/wjg.v16.i45.5710] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
521 Guajardo-Salinas GE, Hilmy A. Prevalence of nonalcoholic fatty liver disease (NAFLD) and utility of FIBROspect II to detect liver fibrosis in morbidly obese Hispano-American patients undergoing gastric bypass. Obes Surg. 2010;20:1647-1653. [PMID: 19957049 DOI: 10.1007/s11695-009-0027-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
522 Li JF, Qu F, Zheng SJ, Ren JY, Wu HL, Liu M, Liu H, Ren F, Chen Y, Zhang JL, Duan ZP. Plasma sphingolipids as potential indicators of hepatic necroinflammation in patients with chronic hepatitis C and normal alanine aminotransferase level. PLoS One 2014;9:e95095. [PMID: 24736528 DOI: 10.1371/journal.pone.0095095] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
523 Fang F, Fang J, Li Q, Tai DI, Wan YL, Tamura K, Yamaguchi T, Tsui PH. Ultrasound Assessment of Hepatic Steatosis by Using the Double Nakagami Distribution: A Feasibility Study. Diagnostics (Basel) 2020;10:E557. [PMID: 32759867 DOI: 10.3390/diagnostics10080557] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
524 Ohkoshi S, Hirono H, Watanabe K, Hasegawa K, Kamimura K, Yano M. Natural regression of fibrosis in chronic hepatitis B. World J Gastroenterol 2016; 22(24): 5459-5466 [PMID: 27350724 DOI: 10.3748/wjg.v22.i24.5459] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
525 Kumar R, Rastogi A, Sharma MK, Bhatia V, Tyagi P, Sharma P, Garg H, Chandan Kumar KN, Bihari C, Sarin SK. Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation. Dig Dis Sci 2013;58:265-74. [PMID: 22790906 DOI: 10.1007/s10620-012-2306-1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
526 Zhan YT, Li L, Weng J, Song X, Yang SQ, An W. Serum autofluorescence, a potential serum marker for the diagnosis of liver fibrosis in rats. Int J Mol Sci. 2012;13:12130-12139. [PMID: 23109905 DOI: 10.3390/ijms130912130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
527 Chen YP, Peng J, Hou JL. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Hepatol Int 2013;7:356-68. [PMID: 26201770 DOI: 10.1007/s12072-013-9439-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
528 Zhang Y, Wang C, Duanmu Y, Zhang C, Zhao W, Wang L, Cheng X, Veronese N, Guglielmi G. Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis. Br J Radiol 2018;91:20170587. [PMID: 30028193 DOI: 10.1259/bjr.20170587] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
529 Parmar KL, O'Reilly D, Valle JW, Braun M, Naish JH, Williams SR, Lloyd WK, Malcomson L, Cresswell K, Bamford C, Renehan AG. Prospective study of change in liver function and fat in patients with colorectal liver metastases undergoing preoperative chemotherapy: protocol for the CLiFF Study. BMJ Open 2020;10:e027630. [PMID: 32967864 DOI: 10.1136/bmjopen-2018-027630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
530 Kohlhaas A, Durango E, Millonig G, Bastard C, Sandrin L, Golriz M, Mehrabi A, Büchler MW, Seitz HK, Mueller S. Transient elastography with the XL probe rapidly identifies patients with nonhepatic ascites. Hepat Med. 2012;4:11-18. [PMID: 24367229 DOI: 10.2147/hmer.s30256] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
531 Choi B, Choi IY, Cha SH, Yeom SK, Chung HH, Lee SH, Cha J, Lee JH. Feasibility of computed tomography texture analysis of hepatic fibrosis using dual-energy spectral detector computed tomography. Jpn J Radiol 2020;38:1179-89. [PMID: 32666182 DOI: 10.1007/s11604-020-01020-5] [Reference Citation Analysis]
532 Wildman-Tobriner B, Middleton MM, Moylan CA, Rossi S, Flores O, Chang ZA, Abdelmalek MF, Sirlin CB, Bashir MR. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis. Gastroenterology 2018;155:1428-1435.e2. [PMID: 30031769 DOI: 10.1053/j.gastro.2018.07.018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
533 Ali AH, Panchal S, Rao DS, Gan Y, Al-Juboori A, Samiullah S, Ibdah JA, Hammoud GM. The efficacy and safety of endoscopic ultrasound-guided liver biopsy versus percutaneous liver biopsy in patients with chronic liver disease: a retrospective single-center study. J Ultrasound 2020;23:157-67. [PMID: 32141043 DOI: 10.1007/s40477-020-00436-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
534 Chung GE, Kim D. Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis. Clin Mol Hepatol 2013;19:116-9. [PMID: 23837135 DOI: 10.3350/cmh.2013.19.2.116] [Reference Citation Analysis]
535 Li J, Dong XQ, Wu Z, Ma AL, Xie SB, Zhang XQ, Zhang ZQ, Zhang DZ, Zhao WF, Zhang G, Cheng J, Xie Q, Li J, Zou ZQ, Liu YX, Wang GQ, Zhao H; China Hepatitis B Related Fibrosis Assessment Research Group. Unsatisfying antiviral therapeutic effect in patients with mother-to-child transmissed chronic hepatitis B virus infection: a prospective multi-center clinical study. Chin Med J (Engl) 2019;132:2647-56. [PMID: 31725459 DOI: 10.1097/CM9.0000000000000522] [Reference Citation Analysis]
536 Liu Y, Jiang M, Xue J, Yan H, Liang X. Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection. BMC Gastroenterol 2019;19:53. [PMID: 30991954 DOI: 10.1186/s12876-019-0966-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
537 Moon KM, Kim G, Baik SK, Choi E, Kim MY, Kim HA, Cho MY, Shin SY, Kim JM, Park HJ. Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis. Clin Mol Hepatol. 2013;19:389-398. [PMID: 24459644 DOI: 10.3350/cmh.2013.19.4.3890] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
538 Kukuk GM, Hittatiya K, Sprinkart AM, Eggers H, Gieseke J, Block W, Moeller P, Willinek WA, Spengler U, Trebicka J, Fischer HP, Schild HH, Träber F. Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis. Eur Radiol 2015;25:2869-79. [PMID: 25903702 DOI: 10.1007/s00330-015-3703-6] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 11.5] [Reference Citation Analysis]
539 Liao YY, Yang KC, Lee MJ, Huang KC, Chen JD, Yeh CK. Multifeature analysis of an ultrasound quantitative diagnostic index for classifying nonalcoholic fatty liver disease. Sci Rep 2016;6:35083. [PMID: 27734972 DOI: 10.1038/srep35083] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]